General Information of Drug (ID: DMGVH6N)

Drug Name
Axitinib
Synonyms
AG 013736; AG013736; AG-013736; AG-13736; AG-013736, Axitinib; N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide; N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; Axitinib (VEGFR inhibitor)
Indication
Disease Entry ICD 11 Status REF
Renal cell carcinoma 2C90 Approved [1]
Therapeutic Class
Anticancer Agents
Affected Organisms
Humans and other mammals
ATC Code
L01EK01: Axitinib
L01EK: Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
L01E: PROTEIN KINASE INHIBITORS
L01: ANTINEOPLASTIC AGENTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 386.5
Logarithm of the Partition Coefficient (xlogp) 4.2
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 4
ADMET Property
BDDCS Class
Biopharmaceutics Drug Disposition Classification System (BDDCS) Class 2: low solubility and high permeability [2]
Clearance
The drug present in the plasma can be removed from the body at the rate of 5 mL/min/kg [3]
Half-life
The concentration or amount of drug in body reduced by one-half in 4.3 hours [3]
Unbound Fraction
The unbound fraction of drug in plasma is 0.004% [3]
Chemical Identifiers
Formula
C22H18N4OS
IUPAC Name
N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
Canonical SMILES
CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4
InChI
InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+
InChIKey
RITAVMQDGBJQJZ-FMIVXFBMSA-N
Cross-matching ID
PubChem CID
6450551
ChEBI ID
CHEBI:66910
CAS Number
319460-85-0
UNII
C9LVQ0YUXG
DrugBank ID
DB06626
TTD ID
D01ZRI
VARIDT ID
DR00035
INTEDE ID
DR0162
ACDINA ID
D00053
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Vascular endothelial growth factor receptor 2 (KDR) TTUTJGQ VGFR2_HUMAN Modulator [4]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
Organic anion transporting polypeptide 1B1 (SLCO1B1) DT3D8F0 SO1B1_HUMAN Substrate [5]
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [5]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Substrate [6]
UDP-glucuronosyltransferase 1A1 (UGT1A1) DEYGVN4 UD11_HUMAN Substrate [6]
Mephenytoin 4-hydroxylase (CYP2C19) DEGTFWK CP2CJ_HUMAN Substrate [6]
Cytochrome P450 1A2 (CYP1A2) DEJGDUW CP1A2_HUMAN Substrate [6]
Cytochrome P450 3A5 (CYP3A5) DEIBDNY CP3A5_HUMAN Substrate [6]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Cellular tumor antigen p53 (TP53) OTIE1VH3 P53_HUMAN Gene/Protein Processing [7]
Cytochrome P450 3A4 (CYP3A4) OTQGYY83 CP3A4_HUMAN Gene/Protein Processing [8]
Mitogen-activated protein kinase 1 (MAPK1) OTH85PI5 MK01_HUMAN Post-Translational Modifications [9]
Mitogen-activated protein kinase 3 (MAPK3) OTCYKGKO MK03_HUMAN Post-Translational Modifications [9]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Renal cell carcinoma
ICD Disease Classification 2C90
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Vascular endothelial growth factor receptor 2 (KDR) DTT KDR 1.98E-01 0.11 0.2
P-glycoprotein 1 (ABCB1) DTP P-GP 9.39E-02 1.07E-01 2.80E-01
Organic anion transporting polypeptide 1B1 (SLCO1B1) DTP OATP1B1 8.15E-01 6.20E-03 5.61E-02
UDP-glucuronosyltransferase 1A1 (UGT1A1) DME UGT1A1 1.10E-01 -5.91E-02 -3.60E-01
Cytochrome P450 1A2 (CYP1A2) DME CYP1A2 7.36E-01 1.62E-02 1.08E-01
Cytochrome P450 3A5 (CYP3A5) DME CYP3A5 9.96E-01 -3.17E-03 -1.84E-02
Mephenytoin 4-hydroxylase (CYP2C19) DME CYP2C19 2.40E-01 -3.31E-02 -1.97E-01
Cytochrome P450 3A4 (CYP3A4) DME CYP3A4 1.04E-02 6.29E-02 3.54E-01
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

Experimental Cancer Drug Sensitivity Information

Cancer Drug Sensitivity Data Curated from 45 Cell Line(s) in Bone Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
RPMI-3460/CS1 GDSC1; GDSC2 3.7829 7.7398 1.4844 9.9591
H-EMC-SS GDSC1; GDSC2 -2.5571 24.3728 -12.4304 51.4431
ES8 GDSC1; GDSC2 0.1163 1.8129 0.0924 31.1721
ES5 GDSC1; GDSC2 0.4714 3.5467 0.1469 29.2143
SK-ES-1 GDSC1; GDSC2; CTRP2 1.0926 2.3672 1.0924 32.9903
ES7 GDSC1; GDSC2 1.2338 4.1668 0.7672 22.6597
EW-12 GDSC2 1.2525 3.1956 1.0967 21.5818
EW-18 GDSC1; GDSC2 1.4131 4.1016 0.9838 20.7416
MHH-ES-1 GDSC1; GDSC2; CTRP2 1.4246 3.7144 1.4001 30.8597
ES1 GDSC1; GDSC2 1.436 3.5714 1.1906 19.5327
EW-22 GDSC1; GDSC2 1.5011 3.3336 1.3316 18.5025
CADO-ES1 GDSC1; GDSC2 1.5105 3.1233 1.3956 18.1274
SK-PN-DW GDSC1; GDSC2 1.6996 4.9237 0.9541 19.7448
G-292 clone A141B1 GDSC1; GDSC2; CTRP2 1.8082 5.1236 1.6362 28.8035
TC-71 GDSC1; GDSC2 1.8422 4.0533 1.4616 16.351
SK-N-MC CTRP2 1.8429 4.3377 1.7881 28.1754
CAL-78 GDSC1; GDSC2; CTRP2 1.8988 4.1738 1.8617 27.7431
NOS-1 [Human HNSCC] GDSC1; GDSC2 1.9071 11.2998 -1.8998 31.2656
HuO9 GDSC1; GDSC2 2.0291 7.208 0.2187 22.4488
TC71 CTRP2 2.2278 6.6053 1.7136 27.2019
CHSA0011 GDSC1; GDSC2 2.2387 9.7432 -0.8308 26.4551
A-673 GDSC1; GDSC2; CTRP2 2.5878 5.6674 2.368 23.7867
CAL-72 GDSC1; GDSC2 2.8871 5.3436 1.9292 9.8162
EW-7 GDSC1; GDSC2 2.9857 6.0589 1.664 11.1085
HuO-3N1 GDSC1; GDSC2 3.3625 7.9869 1.0231 13.7901
SaOS-2 GDSC1; GDSC2; CTRP2 3.7059 7.2456 3.087 17.8338
EW-13 GDSC1; GDSC2 3.7422 6.2626 2.1855 5.8516
EW-3 GDSC1; GDSC2 3.7917 7.7982 1.4623 10.0678
EW-24 GDSC1; GDSC2 3.896 6.5191 2.1729 5.5655
EW-11 GDSC1; GDSC2 4.0164 9.4833 0.7992 13.2918
U-CH2 GDSC2 4.044 9.3518 0.8855 13.1612
NY GDSC1; GDSC2 4.0838 8.6146 1.2806 10.4033
EW-16 GDSC1; GDSC2 4.1965 7.5484 1.8857 6.5974
ES4 GDSC1; GDSC2 4.2042 6.4759 2.4057 3.5543
EW-1 GDSC1; GDSC2 4.2536 9.7193 0.8626 12.352
U2OS GDSC1; GDSC2 4.3111 8.7598 1.3768 9.3107
ES6 GDSC1; GDSC2 4.3393 7.3567 2.0765 5.1828
CHSA0108 GDSC1; GDSC2 4.4937 8.9769 1.4014 8.7594
SJSA-1 GDSC1; GDSC2; CTRP2 4.6223 7.6887 3.8639 12.3388
MG-63 GDSC1; GDSC2; CTRP2 4.7864 9.1622 3.3439 14.0245
Hs 888.T CTRP2 5.1768 14.9203 0.8642 22.3157
HOS GDSC1; GDSC2; CTRP2 5.3232 9.787 3.5426 11.9842
CHSA8926 GDSC1; GDSC2 5.7127 16.3928 -1.344 19.1461
Hs 822.T CTRP2 5.9951 12.6055 2.7227 13.9195
SW1353 CTRP2 7.5751 16.6695 1.9473 13.981
⏷ Show the Full List of 45 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 218 Cell Line(s) in Haematopoietic And Lymphoid Tissue Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
JK1 CTRP2 -3.2622 2.0972 -3.3673 60.8588
MEC1 CTRP2 3.6435 6.6117 3.2499 17.4005
JM1 GDSC1; GDSC2; CTRP2 2.7499 5.5897 2.5621 22.5957
EoL-1 GDSC1; GDSC2; CTRP2 -10.9186 -8.8034 -10.9186 99.2075
Kasumi-1 GDSC1; GDSC2; CTRP2 -5.503 -1.6666 -5.5077 75.4462
Ku812 GDSC1; GDSC2; CTRP2 -2.9933 -0.7741 -2.9936 60.1932
JURL-MK1 GDSC1; GDSC2; CTRP2 -2.7223 -1.1537 -2.7223 58.4041
NCO2 CTRP2 -2.4986 -1.1099 -2.4986 56.9146
LAMA-84 GDSC1; GDSC2; CTRP2 -2.4618 -1.1622 -2.4618 56.6695
MEG-01 GDSC1; GDSC2 -2.068 0.045 -2.075 52.1973
EM-2 GDSC1; GDSC2; CTRP2 -2.0167 0.6686 -2.0201 53.688
MOLM-6 CTRP2 -1.6439 0.6444 -1.6452 51.2187
ALL-SIL GDSC1; GDSC2; CTRP2 -1.515 0.0139 -1.5151 50.362
BV-173 GDSC1; GDSC2; CTRP2 -1.3569 1.1868 -1.3608 49.3105
BE-13 GDSC1; GDSC2 -1.2714 0.8634 -1.2885 44.5582
CML-T1 GDSC1; GDSC2; CTRP2 -1.2132 1.1136 -1.2155 48.3541
KYO-1 CTRP2 -1.209 -0.4571 -1.209 48.323
KCL-22 GDSC1; GDSC2; CTRP2 -0.782 1.2198 -0.7831 45.4813
KG-1 GDSC1; GDSC2 -0.5965 2.6592 -0.7934 38.7582
MY-M12 GDSC1; GDSC2 -0.4684 3.4808 -0.8591 38.2624
ATN-1 GDSC1; GDSC2 -0.4629 0.4715 -0.463 36.6685
Peer CTRP2 -0.441 1.0035 -0.4411 43.2068
NALM-6 GDSC1; GDSC2; CTRP2 -0.3106 1.1928 -0.3107 42.3384
K-562 GDSC1; GDSC2; CTRP2 -0.0985 3.288 -0.1547 41.0814
SUP-M2 GDSC1; GDSC2; CTRP2 -0.0513 1.6516 -0.0519 40.6124
HuT 78 CTRP2 0.0861 8.0011 -1.0808 42.0253
SUP-B15 GDSC1; GDSC2; CTRP2 0.0899 2.4731 0.0809 39.698
BL-41 GDSC1; GDSC2 0.1312 0.8262 0.1312 30.9118
NKM-1 GDSC1; GDSC2 0.2496 4.8768 -0.5545 33.3874
ALL-PO GDSC1; GDSC2 0.3326 2.9087 0.1624 29.7936
P32/ISH GDSC1; GDSC2 0.3846 1.2209 0.3842 28.4591
697 GDSC1; GDSC2; CTRP2 0.3906 1.4909 0.3906 37.6663
RS4;11 GDSC1; GDSC2; CTRP2 0.4014 1.4088 0.4014 37.5943
MOLT-4 GDSC1; GDSC2 0.4661 2.2198 0.4227 27.8799
CRO-AP2 GDSC1; GDSC2 0.4781 2.4025 0.4124 27.8739
MV4-11 GDSC1; GDSC2; CTRP2 0.5072 2.1779 0.5062 36.8929
MOLT-16 GDSC1; GDSC2; CTRP2 0.5133 1.4342 0.5133 36.8492
SU-DHL-16 GDSC1; GDSC2 0.6465 2.0571 0.6269 26.0157
A4/Fukuda GDSC1; GDSC2; CTRP2 0.6577 5.1922 0.3746 36.733
NB4 GDSC1; GDSC2; CTRP2 0.667 1.6672 0.667 35.8252
MOLM-13 GDSC1; GDSC2; CTRP2 0.6791 2.6439 0.6747 35.7589
SU-DHL-5 GDSC1; GDSC2 0.6987 2.191 0.6708 25.5505
SEM CTRP2 0.7046 1.4943 0.7046 35.5742
CCRF-CEM GDSC1; GDSC2 0.8383 2.3753 0.7993 24.2533
KMS-26 CTRP2 0.8689 4.3043 0.7587 34.8339
KE-37 GDSC1; GDSC2; CTRP2 0.8712 2.9323 0.8637 34.4896
QIMR-WIL GDSC1; GDSC2 0.896 2.576 0.8345 23.8063
P31/FUJ GDSC1; GDSC2; CTRP2 0.9023 2.4392 0.9014 34.2607
P30/OHK GDSC1; GDSC2 0.9099 1.8229 0.9074 23.3804
Kasumi-2 CTRP2 0.9147 3.247 0.898 34.2299
KMS-21-BM CTRP2 0.974 3.2787 0.9575 33.8345
SUP-B8 GDSC1; GDSC2 0.9803 1.9583 0.9758 22.7078
BC-3 GDSC2 1.0257 3.8366 0.6587 24.9838
ST486 GDSC1; GDSC2; CTRP2 1.0319 3.6161 0.9992 33.502
NU-DUL-1 GDSC1; GDSC2; CTRP2 1.047 2.6453 1.0251 23.3776
KOPN-8 GDSC1; GDSC2 1.11 2.2324 1.0967 21.4939
OCI-Ly19 GDSC1; GDSC2; CTRP2 1.1261 2.4351 1.1258 32.7675
KY821 GDSC1; GDSC2 1.1379 4.624 0.4894 24.5284
P12-Ichikawa GDSC1; GDSC2; CTRP2 1.1547 2.0971 1.1547 32.5756
IM-9 GDSC1; GDSC2 1.1643 1.8541 1.1636 20.9069
GDM-1 GDSC1; GDSC2; CTRP2 1.1956 3.6315 1.168 32.3953
TALL-1 [Human adult T-ALL] GDSC2; CTRP2 1.2164 3.2947 1.205 32.2027
OCI-AML-5 GDSC1; GDSC2; CTRP2 1.2417 3.4659 1.2242 32.0543
CTB-1 GDSC1; GDSC2 1.2627 3.8941 0.8959 21.8503
MOLT-3 CTRP2 1.2665 2.9574 1.2634 31.8417
KO52 CTRP2 1.2668 3.8271 1.2288 31.9553
ML-2 GDSC1; GDSC2 1.2735 3.6554 0.9872 21.3187
JVM-3 GDSC1; GDSC2; CTRP2 1.2799 3.8492 0.93 18.1466
KMS-11 GDSC1; GDSC2; CTRP2 1.281 4.9427 1.1 32.33
HAL-01 GDSC1; GDSC2 1.2992 3.1396 1.1614 20.2907
LC4-1 GDSC1; GDSC2 1.3157 4.0576 0.8952 21.6291
DEL GDSC1; GDSC2; CTRP2 1.3166 3.3207 1.3064 31.5313
VAL GDSC1; GDSC2 1.3206 3.5499 1.0716 20.6662
MOLM-16 GDSC1; GDSC2; CTRP2 1.3572 3.5534 1.339 31.2876
RPMI-8866 GDSC1; GDSC2 1.3931 4.1729 0.9358 21.0849
BONNA-12 GDSC2 1.3946 4.3164 0.8828 22.1232
OPM-2 GDSC1; GDSC2; CTRP2 1.449 3.7063 1.4258 30.6926
Loucy GDSC1; GDSC2 1.4741 3.6719 1.2 19.3183
GA-10 GDSC1; GDSC2; CTRP2 1.4846 3.268 1.4788 30.3973
RPMI-8402 GDSC1; GDSC2; CTRP2 1.5192 3.6387 1.5017 30.2059
L-540 GDSC1; GDSC2; CTRP2 1.5578 4.1783 1.5036 30.072
DoHH2 GDSC1; GDSC2; CTRP2 1.573 2.8722 1.5724 29.7909
EB1 CTRP2 1.5846 5.0188 1.4141 30.2832
BALL-1 GDSC1; GDSC2 1.6072 3.8756 1.2748 18.3496
MJ CTRP2 1.6107 14.2883 -2.1755 38.4805
Sc-1 GDSC1 1.6267 3.0419 0.4421 2.5811
Farage GDSC1; GDSC2 1.6305 3.219 1.5031 17.0312
SU-DHL-10 GDSC2; CTRP2 1.6698 3.709 1.6533 29.1992
Karpas-45 GDSC1; GDSC2 1.6821 4.336 1.1807 18.5574
OCI-AML-3 GDSC1; GDSC2; CTRP2 1.6867 5.5016 1.4252 29.9103
WSU-NHL GDSC1; GDSC2 1.7202 4.0466 1.3337 17.5569
Reh GDSC1; GDSC2; CTRP2 1.7227 3.6413 1.7104 28.8328
OCI-AML-2 GDSC1; GDSC2; CTRP2 1.7468 3.2447 1.7443 28.6394
OCI-Ly7 GDSC1; GDSC2 1.8162 3.8691 1.5024 16.2337
Daudi GDSC1; GDSC2; CTRP2 1.831 2.9672 1.8307 28.0715
Ramos.2G6.4C10 GDSC1; GDSC2 1.8452 4.5684 1.2569 17.4819
MOTN-1 CTRP2 1.8966 4.5106 1.8259 27.8715
RCH-ACV GDSC1; GDSC2; CTRP2 1.9791 5.1148 1.8227 27.6143
SCC-3 GDSC2 2.0268 6.6413 0.4892 21.7565
MHH-CALL-2 GDSC1; GDSC2 2.0367 4.081 1.6579 14.4716
KMS-34 CTRP2 2.087 4.6383 2.0126 26.616
AML-193 CTRP2 2.1264 6.0063 1.7789 27.2947
SKM-1 GDSC1; GDSC2; CTRP2 2.1371 5.2897 1.9601 26.6344
HPB-ALL CTRP2 2.1899 4.9187 2.0832 26.0411
MOLT-13 GDSC1; GDSC2; CTRP2 2.2914 5.0809 2.1657 25.4308
SIG-M5 GDSC2; CTRP2 2.3352 3.615 2.3332 24.7176
KE-97 CTRP2 2.3513 5.358 2.1786 25.1949
LP-1 GDSC1; GDSC2; CTRP2 2.355 4.0733 2.3412 24.6254
KM-H2 GDSC1; GDSC2; CTRP2 2.3639 5.8403 2.0816 25.4939
KMS-20 CTRP2 2.3791 5.7401 2.1231 25.301
GR-ST GDSC1; GDSC2 2.4043 6.6429 0.8461 17.7804
JeKo-1 GDSC1; GDSC2; CTRP2 2.4078 5.4143 2.2282 24.8433
SU-DHL-8 GDSC2; CTRP2 2.4149 5.0399 2.3056 24.5521
NOMO-1 GDSC1; GDSC2; CTRP2 2.4452 5.4616 2.2589 24.6176
SUP-T11 CTRP2 2.4486 5.3558 2.2844 24.5181
JSC-1 GDSC1; GDSC2 2.489 5.4536 1.5017 13.6967
F-36P CTRP2 2.515 5.8163 2.2525 24.4211
BC-1 GDSC1; GDSC2 2.6008 4.5616 2.032 10.1734
M-07e CTRP2 2.6276 6.4264 2.2046 24.2443
Mono-Mac-6 GDSC1; GDSC2 2.631 5.1809 1.7685 11.6283
TUR GDSC1; GDSC2 2.6341 6.9768 0.8938 16.747
RPMI-6666 GDSC1; GDSC2; CTRP2 2.6348 4.9755 2.5514 22.9984
KMS-18 CTRP2 2.653 5.9755 2.3619 23.6054
KHM-1B CTRP2 2.7284 5.1189 1.7385 7.7259
HL-60 GDSC1; GDSC2; CTRP2 2.7521 5.3704 2.6104 22.4195
Namalwa GDSC1; GDSC2; CTRP2 2.7629 5.8268 2.5202 22.7031
SUP-HD1 GDSC1; GDSC2; CTRP2 2.7714 5.7941 2.5376 22.6152
BL-70 CTRP2 2.7722 5.7995 2.5371 22.6146
KMS-28BM CTRP2 2.8323 6.0771 2.5299 22.4548
A3/Kawakami GDSC1; GDSC2; CTRP2 2.8667 5.6764 2.6696 21.8513
DB GDSC1; GDSC2; CTRP2 2.9131 6.3071 2.5519 22.1297
SET-2 CTRP2 2.9455 5.9642 2.684 21.5563
SU-DHL-6 GDSC1; GDSC2; CTRP2 2.9527 5.8241 2.7278 21.3778
ARH-77 GDSC1; GDSC2 2.9566 5.4789 1.9257 9.6169
KMOE-2 GDSC1; GDSC2 2.978 6.6907 1.343 13.0529
MOLP-8 GDSC1; GDSC2; CTRP2 2.9814 7.743 2.1222 23.4919
SUP-T1 GDSC1; GDSC2; CTRP2 2.9835 6.1347 2.6788 21.4585
NU-DHL-1 CTRP2 3.0085 5.3505 2.8917 20.6252
Ki-JK CTRP2 3.0454 8.4718 1.8942 24.1305
PL-21 GDSC1; GDSC2 3.0502 7.3851 1.0597 14.4935
Ri-1 CTRP2 3.081 5.8292 2.8665 20.4874
HC-1 GDSC1; GDSC2 3.0951 5.907 1.8358 9.7367
L-363 GDSC1; GDSC2; CTRP2 3.1853 6.1013 2.9084 20.0171
JJN-3 GDSC1; GDSC2; CTRP2 3.2251 6.4914 2.8349 20.1646
CTV-1 GDSC1; GDSC2 3.2383 6.8066 1.5094 11.2873
RPMI-8226 GDSC1; GDSC2; CTRP2 3.2558 6.5404 2.8525 20.0088
DND-41 GDSC1; GDSC2; CTRP2 3.2772 6.6535 2.8387 19.9964
NK-92MI GDSC2 3.2803 5.9267 1.9847 8.5854
CA46 GDSC1; GDSC2; CTRP2 3.2814 6.0132 3.0375 19.2595
KMS-12-BM GDSC1; GDSC2; CTRP2 3.2956 5.8012 3.1073 18.9657
VL51 GDSC1; GDSC2 3.3067 5.9508 1.9948 8.153
Mono-Mac-1 CTRP2 3.3907 6.2257 3.0968 18.7133
TF-1 CTRP2 3.4044 5.9851 3.1793 18.3737
Granta-519 GDSC1; GDSC2; CTRP2 3.4066 6.4042 3.06 18.7999
Jiyoye GDSC1; GDSC2 3.4092 6.6968 1.7067 9.6172
Hs 611.T CTRP2 3.4106 6.3136 3.0922 18.6703
Karpas-422 GDSC1; GDSC2; CTRP2 3.4149 6.8974 2.9037 19.3532
Karpas-231 GDSC1; GDSC2 3.4312 6.0653 2.0402 7.5318
RC-K8 GDSC1; GDSC2 3.4677 6.2703 1.9673 7.8765
CESS GDSC1; GDSC2 3.4731 6.0491 2.0821 7.1632
PF-382 GDSC1; GDSC2; CTRP2 3.4977 8.0402 2.5475 20.4591
WIL2 NS GDSC1; GDSC2 3.5069 7.1166 1.5765 10.1346
SU-DHL-1 GDSC2; CTRP2 3.5254 6.4788 3.1655 18.0599
MHH-CALL-4 GDSC2; CTRP2 3.5328 6.6975 3.1009 18.2773
EB2 GDSC1; GDSC2 3.5473 5.8207 2.255 5.9154
L-428 GDSC1; GDSC2; CTRP2 3.5612 7.8831 2.679 19.7866
PL21 CTRP2 3.5879 6.0976 3.3488 17.2036
WSU-DLCL2 GDSC1; GDSC2; CTRP2 3.5884 6.1643 3.3305 17.2683
HH [Human lymphoma] GDSC1; GDSC2 3.6019 6.0912 2.1631 6.3345
RL GDSC1; GDSC2; CTRP2 3.6537 6.4326 3.3199 17.1119
MHH-CALL-3 CTRP2 3.6894 6.9549 3.1786 17.5344
U-698-M GDSC1; GDSC2 3.7008 6.4999 2.0366 6.8527
MM1.S GDSC1; GDSC2; CTRP2 3.7342 6.3287 3.4402 16.4307
MLMA GDSC1; GDSC2 3.7688 6.4428 2.1164 6.2039
TK [Human B-cell lymphoma] GDSC1; GDSC2 3.7787 6.1823 2.2523 5.362
OCI-M1 GDSC1; GDSC2; CTRP2 3.7828 7.47 3.0806 17.6435
CMK GDSC1; CTRP2 3.8091 6.2649 3.5413 15.8371
MN-60 GDSC1; GDSC2 3.8234 7.8095 1.4811 9.8759
SR GDSC1; GDSC2; CTRP2 3.8365 6.5377 3.4841 15.967
U266B1 GDSC1; GDSC2; CTRP2 3.8575 6.2686 3.593 15.5033
H9 GDSC1; GDSC2 3.882 10.1587 0.3584 15.9962
Jurkat GDSC1; GDSC2; CTRP2 3.9491 7.599 3.2035 16.7148
L-1236 GDSC1; GDSC2; CTRP2 3.9603 7.2969 3.3375 16.1683
MHH-PREB-1 GDSC1; GDSC2 3.9656 8.1805 1.4061 9.9627
ROS-50 GDSC1; GDSC2 4.0109 7.1214 1.9614 6.565
YT GDSC1; GDSC2 4.0704 5.9122 2.5848 2.7873
U-937 CTRP2 4.0858 5.7868 3.9714 13.4437
ME1 CTRP2 4.088 6.6466 3.7191 14.3593
HEL 92.1.7 CTRP2 4.1927 9.2781 2.7088 18.0059
SU-DHL-4 GDSC1; GDSC2; CTRP2 4.2719 7.546 3.5634 14.445
Hs 445 GDSC2 4.302 6.748 2.3405 3.8747
DG-75 GDSC1; GDSC2 4.37 7.276 2.1353 4.7829
HD-MY-Z CTRP2 4.3702 7.2325 3.7966 13.2729
HEL GDSC1; GDSC2; CTRP2 4.3825 8.5414 3.2373 15.444
ME1 GDSC1; GDSC2 4.489 8.6426 1.5602 7.8585
SK-MM-2 GDSC1; GDSC2; CTRP2 4.4988 6.3178 4.2757 11.0899
KMS-27 CTRP2 4.536 10.162 2.6245 17.4908
THP-1 GDSC1; GDSC2; CTRP2 4.5473 6.2714 4.3433 10.6974
P3HR-1 CTRP2 4.607 7.7969 3.8003 12.6312
REC-1 CTRP2 4.609 7.632 3.8753 12.3284
MOLP-2 CTRP2 4.7247 7.8904 3.8776 12.0219
OCI-Ly3 CTRP2 4.7392 7.0733 4.2497 10.5122
AMO1 GDSC1; CTRP2 4.8602 7.7975 4.0562 10.9638
Karpas-620 GDSC1; GDSC2; CTRP2 5.0274 6.8027 4.6639 8.1214
Karpas-1106P GDSC1; GDSC2 5.0389 6.3816 2.8802 0.3462
OCI-Ly10 CTRP2 5.0781 7.8095 4.2676 9.5698
EJM GDSC1; GDSC2; CTRP2 5.1233 7.1214 4.6267 8.0138
Toledo CTRP2 5.2048 7.7978 4.3975 8.7338
JVM-2 GDSC1; GDSC2; CTRP2 5.2977 8.627 4.088 9.7869
Ci-1 CTRP2 5.6282 5.9665 5.6089 2.8391
HT GDSC1; GDSC2; CTRP2 5.944 10.3077 3.8285 9.5024
EHEB GDSC1; CTRP2 5.9474 10.6254 3.6726 10.1452
HDLM-2 GDSC1; GDSC2; CTRP2 6.744 13.9297 2.6686 12.7179
Karpas-299 GDSC1; GDSC2; CTRP2 6.8166 10.5098 4.418 5.4816
KMM-1 CTRP2 7.0773 11.8733 3.9395 7.033
MC116 GDSC1; GDSC2; CTRP2 7.3437 11.9899 4.0725 6.085
NCI-H929 GDSC1; GDSC2; CTRP2 7.4505 11.6737 4.2978 5.0275
Raji GDSC1; GDSC2; CTRP2 7.6077 11.9303 4.2801 4.8826
⏷ Show the Full List of 218 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 28 Cell Line(s) in Oesophagus Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
TE8 CTRP2 3.1837 6.0481 2.9214 19.9753
TE15 CTRP2 3.8648 7.0824 3.3192 16.5048
TE-8 GDSC1; GDSC2 3.522 5.8458 2.2226 6.1785
EC-GI-10 GDSC1; GDSC2; CTRP2 3.5337 7.0922 2.9608 18.7982
TE-6 GDSC1; GDSC2; CTRP2 3.7237 5.795 3.5752 15.9748
KYSE-140 GDSC1; GDSC2; CTRP2 3.9251 7.474 3.2293 16.6805
TE-15 GDSC1; GDSC2 4.1683 6.4633 2.3882 3.7229
TE-11 GDSC1; GDSC2; CTRP2 4.2032 8.7815 2.9479 17.0432
T.T GDSC1; GDSC2 4.3251 7.1191 2.1802 4.6127
KYSE-270 GDSC1; GDSC2 4.6125 6.8707 2.4727 2.4956
KYSE-510 GDSC1; GDSC2; CTRP2 4.655 7.0083 4.1879 10.9806
KYSE-410 GDSC1; GDSC2; CTRP2 4.8275 8.7909 3.5604 13.0487
KYSE-450 GDSC1; GDSC2; CTRP2 4.9322 8.1508 3.9644 11.1556
TE-14 CTRP2 5.0555 7.4254 4.4218 9.0047
TE-9 GDSC1; GDSC2; CTRP2 5.0661 9.2261 3.5794 12.4104
TE-5 GDSC1; GDSC2; CTRP2 5.146 7.6656 4.4018 8.8597
TE-4 GDSC1; GDSC2; CTRP2 5.3275 8.9226 3.9715 10.2015
KYSE-150 GDSC1; GDSC2; CTRP2 5.3985 8.9466 4.0252 9.8207
KYSE-30 CTRP2 5.5707 8.7841 4.2622 8.4583
KYSE-70 GDSC1; GDSC2; CTRP2 5.6339 9.4017 4.0125 9.3655
KYSE-520 GDSC1; GDSC2; CTRP2 5.7519 9.1671 4.233 8.197
OE21 GDSC1; GDSC2; CTRP2 6.1258 12.3634 2.9525 12.7475
COLO 680N GDSC1; GDSC2; CTRP2 6.8459 11.2199 4.0904 6.7851
TE-10 GDSC1; GDSC2; CTRP2 7.3001 11.3529 4.3497 5.0315
OE33 GDSC1; GDSC2; CTRP2 7.7848 10.4993 5.0456 1.7999
KYSE-180 GDSC1; GDSC2; CTRP2 8.0747 12.6176 4.2563 4.3786
TE-1 GDSC1; GDSC2; CTRP2 8.1425 12.6478 4.2843 4.1913
OE19 GDSC1; GDSC2; CTRP2 8.436 17.0032 2.4074 10.9442
⏷ Show the Full List of 28 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 41 Cell Line(s) in Pancreas Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
N2a-PK1 CTRP2 5.6676 9.5337 3.9765 9.4448
KP-4 GDSC1; GDSC2; CTRP2 3.524 7.1473 2.9299 18.942
MIA PaCa-2 GDSC1; GDSC2; CTRP2 3.7287 6.6877 3.3163 16.9053
PL4 GDSC1; GDSC2 3.8436 6.3363 2.2243 5.3785
KP-1N GDSC1; GDSC2 4.0271 6.3874 2.3296 4.3483
HuP-T4 GDSC1; GDSC2; CTRP2 4.1298 9.973 2.3218 19.6541
HPAF-II GDSC1; GDSC2 4.327 7.0465 2.2158 4.4044
KP-3 GDSC1; GDSC2; CTRP2 4.3334 7.4964 3.6485 13.9481
DAN-G GDSC1; GDSC2; CTRP2 4.3984 8.2114 3.403 14.7454
Capan-1 GDSC1; GDSC2; CTRP2 4.6455 7.7419 3.864 12.2788
Panc 03.27 GDSC1; GDSC2; CTRP2 4.7276 7.5019 4.0539 11.3125
BxPC-3 GDSC1; GDSC2; CTRP2 4.7964 8.2141 3.8008 12.1511
PSN1 GDSC1; GDSC2; CTRP2 4.8124 8.1305 3.8554 11.8911
PANC-1 CTRP2 4.858 7.1284 4.3503 9.8007
SNU-410 CTRP2 5.0309 9.9449 3.1963 14.0542
Hs 766T GDSC1; GDSC2; CTRP2 5.0943 7.2509 4.5397 8.4347
SW1990 GDSC1; GDSC2; CTRP2 5.1122 8.0775 4.1751 9.8629
SU.86.86 GDSC1; GDSC2; CTRP2 5.2085 8.4095 4.1091 9.9055
Panc 10.05 GDSC1; GDSC2 5.2264 7.7 2.4424 1.8438
Panc 08.13 GDSC1; GDSC2; CTRP2 5.292 7.7424 4.5087 8.0709
Panc 04.03 GDSC1; GDSC2; CTRP2 5.3788 8.0573 4.4409 8.1452
QGP-1 GDSC1; GDSC2; CTRP2 5.3837 11.5983 2.6993 15.2727
HuP-T3 GDSC1; GDSC2; CTRP2 5.405 7.0295 4.9533 5.9905
PaTu 8988s CTRP2 5.5088 7.8807 4.649 6.9883
AsPC-1 GDSC1; GDSC2; CTRP2 5.8095 12.9333 2.4023 15.5432
Panc 02.03 GDSC1; GDSC2; CTRP2 5.8267 9.6408 4.0617 8.7618
Capan-2 GDSC1; GDSC2; CTRP2 5.9225 8.2586 4.8342 5.3272
KP-2 GDSC1; GDSC2; CTRP2 5.9656 8.521 4.7399 5.6374
MZ-PC-1 GDSC1; GDSC2 6.109 8.3374 2.587 0.61
PaTu 8902 GDSC1; GDSC2; CTRP2 6.2413 11.4248 3.5165 10.2269
TCC-Pan2 CTRP2 6.3765 10.0693 4.3015 6.7083
SUIT-2 GDSC1; GDSC2; CTRP2 6.6219 9.3227 4.8581 3.9764
PK-45H CTRP2 7.0594 11.4599 4.1289 6.2869
SNU-213 CTRP2 7.6302 8.6193 5.7258 0.0872
Panc 05.04 CTRP2 7.6762 13.5645 3.5421 7.7188
PK-59 CTRP2 7.7688 12.9214 3.9151 6.1056
PaTu 8988t GDSC1; GDSC2; CTRP2 7.8583 17.7973 1.6027 14.7257
HPAC GDSC1; GDSC2; CTRP2 7.9483 12.6182 4.1764 4.8426
L3.3 CTRP2 7.9736 13.95 3.5609 7.2146
YAPC GDSC1; GDSC2; CTRP2 8.1228 12.7245 4.2366 4.3956
CFPAC-1 GDSC1; GDSC2; CTRP2 8.2709 15.0908 3.2152 8.139
⏷ Show the Full List of 41 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 74 Cell Line(s) in Skin Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SH4 CTRP2 4.6009 6.4059 4.3573 12.1171
A-431 GDSC1; GDSC2 2.46 5.0957 1.6437 12.9605
COLO 792 GDSC1; GDSC2; CTRP2 2.5757 6.4571 2.1387 24.6372
MZ-MEL-2 GDSC1; GDSC2 3.1767 8.372 0.6749 16.285
M14 GDSC1; GDSC2 3.4424 6.2101 1.977 7.886
CP50-MEL-B GDSC1; GDSC2 3.4992 6.6686 1.7939 8.8443
GAK GDSC1; GDSC2 3.6036 5.6363 2.3903 4.9511
CHL-1 GDSC1; GDSC2 3.6394 6.7704 1.8546 8.1086
DJM-1 GDSC1; GDSC2 3.6545 6.2587 2.1207 6.4591
HMV-II GDSC1; GDSC2 3.7381 7.4401 1.5986 9.3944
LOX-IMVI GDSC1; GDSC2; CTRP2 3.7742 6.6784 3.3687 16.5779
A-388 GDSC1; GDSC2 3.8539 8.885 0.9703 12.7557
IST-MEL1 GDSC1; GDSC2 3.9839 6.6512 2.1715 5.3759
G-mel GDSC1; GDSC2 4.0545 8.9592 1.0881 11.5789
COLO 679 GDSC1; GDSC2 4.0577 6.1678 2.4556 3.5513
CJM [Human melanoma] CTRP2 4.1535 6.2885 3.9093 13.4619
Hs 944.T CTRP2 4.1737 5.8626 4.0495 12.893
Hs 940.T GDSC1; GDSC2; CTRP2 4.24 6.8638 3.8035 13.6072
WM35 GDSC1; GDSC2 4.2646 7.5004 1.9566 6.035
RPMI-7951 GDSC1; GDSC2; CTRP2 4.3263 8.2266 3.3231 15.2475
SK-MEL-5 GDSC1; GDSC2; CTRP2 4.3972 5.4384 4.3688 11.0698
SH-4 GDSC1; GDSC2 4.4598 7.0537 2.2976 3.6946
HT-144 GDSC1; GDSC2; CTRP2 4.4996 7.7086 3.7294 13.1905
Hs 895.T CTRP2 4.5023 13.1823 1.1209 23.0211
Mel JuSo GDSC1; GDSC2; CTRP2 4.5169 6.9463 4.0669 11.8269
451Lu GDSC1; GDSC2 4.5726 7.7321 2.0517 4.8714
LB2518-MEL GDSC1; GDSC2 4.6185 6.578 2.6052 1.8142
WM88 CTRP2 4.6433 6.8863 4.2246 10.871
MZ-MEL-7 GDSC1; GDSC2 4.7098 6.393 2.7308 1.123
WM115 GDSC1; GDSC2; CTRP2 4.7122 6.7518 4.3507 10.1963
LB373-MEL-D GDSC1; GDSC2 4.7396 7.5463 2.2416 3.5245
COLO 800 GDSC1; GDSC2; CTRP2 4.8314 6.9806 4.3848 9.7371
WM266-4 CTRP2 4.8444 7.7352 4.0686 10.954
IGR-37 GDSC1; GDSC2; CTRP2 4.9872 7.9384 4.1178 10.3997
WT2-iPS GDSC1; GDSC2; CTRP2 4.9899 7.5159 4.3146 9.6003
WM278 GDSC1; GDSC2 5.0124 7.6513 2.3508 2.5468
A-375 GDSC1; GDSC2; CTRP2 5.026 8.7505 3.771 11.7191
SK-MEL-28 GDSC1; GDSC2; CTRP2 5.0267 7.8233 4.2104 9.9275
MeWo GDSC1; GDSC2; CTRP2 5.0293 7.2463 4.4754 8.8578
SK-MEL-31 GDSC1; GDSC2; CTRP2 5.0571 6.7596 4.7129 7.8503
VMRC-MELG GDSC1; GDSC2 5.1212 7.0158 2.6723 0.9773
Hs 294T CTRP2 5.1597 7.2505 4.6061 8.0026
IGR-1 GDSC1; GDSC2; CTRP2 5.1784 7.5908 4.4686 8.5097
RVH-421 GDSC1; GDSC2; CTRP2 5.2094 7.6281 4.4818 8.3797
SK-MEL-3 GDSC1; GDSC2; CTRP2 5.2171 7.4768 4.5599 8.0449
WM983B CTRP2 5.2624 7.8897 4.4099 8.5453
UACC-62 GDSC1; GDSC2; CTRP2 5.2824 7.6914 4.5235 8.0336
UACC-257 GDSC1; GDSC2; CTRP2 5.2927 8.2568 4.2628 9.0778
COLO 783 GDSC1; GDSC2 5.3534 6.8404 2.8362 0.3181
WM1552C GDSC1; GDSC2 5.3575 7.1382 2.7279 0.6125
CP66-MEL GDSC1; GDSC2 5.3613 6.946 2.801 0.4015
SK-MEL-24 GDSC1; GDSC2; CTRP2 5.3698 9.2094 3.8697 10.5287
MMAc-SF GDSC1; GDSC2 5.5028 7.5039 2.6501 0.77
HMCB CTRP2 5.6477 13.6452 1.9085 17.7319
SK-MEL-2 GDSC1; GDSC2; CTRP2 5.7708 6.2887 5.6561 2.2509
A2058 GDSC1; GDSC2; CTRP2 5.8998 11.1912 3.3495 11.5765
Hs 688(A).T CTRP2 5.9087 11.0467 3.4293 11.2301
Hs 934.T CTRP2 6.0264 11.6297 3.2368 11.7887
COLO 829 GDSC1; GDSC2; CTRP2 6.1378 14.9267 1.6808 17.5584
Hs 938.T GDSC1; GDSC2 6.1922 14.7368 -0.207 13.4738
IGR-39 CTRP2 6.4272 21.0372 -1.1354 25.2762
G-361 GDSC1; GDSC2; CTRP2 6.6898 10.5545 4.302 6.1669
IPC-298 GDSC1; GDSC2; CTRP2 6.9675 11.0054 4.2848 5.7916
K029AX CTRP2 7.0019 12.0174 3.8135 7.6695
A101D GDSC1; GDSC2; CTRP2 7.0762 12.5994 3.582 8.4928
WM1799 CTRP2 7.0923 11.0759 4.3394 5.3774
SK-MEL-1 GDSC1; GDSC2; CTRP2 7.2837 11.6985 4.1717 5.7728
MDA-MB-435S CTRP2 7.36 10.6791 4.7103 3.5186
SK-MEL-30 GDSC1; GDSC2; CTRP2 7.3834 12.4567 3.874 6.8271
Hs 936.T CTRP2 7.4282 10.5289 4.8236 2.9946
Mel Ho GDSC1; GDSC2; CTRP2 7.649 12.3054 4.129 5.4241
WM793 GDSC1; GDSC2; CTRP2 7.8051 11.5942 4.5635 3.534
Hs 839.T CTRP2 8.7581 31.7259 -4.6108 28.0839
EquiPSC Line K2 GDSC1; GDSC2 5.8983 15.9258 -0.9834 17.3609
⏷ Show the Full List of 74 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 11 Cell Line(s) in Aero Dig Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
OACP4 C GDSC1; GDSC2 2.4268 6.6366 0.8701 17.5689
TE-12 GDSC1; GDSC2 2.8214 6.4313 1.3327 13.601
KYSE-220 GDSC1; GDSC2 2.8758 5.6853 1.7506 10.9296
OACM5.1 C GDSC1; GDSC2 3.1173 6.5276 1.5455 11.4244
HCE-4 GDSC1; GDSC2 3.2362 7.3103 1.2558 12.8001
FLO-1 GDSC1; GDSC2 3.5526 7.5085 1.4177 10.9589
KYSE-50 GDSC1; GDSC2 3.7286 5.8538 2.3768 4.7308
ESO-26 GDSC1; GDSC2 3.9279 7.2991 1.813 7.644
ESO-51 GDSC1; GDSC2 4.5514 6.7223 2.5041 2.4236
SK-GT-4 GDSC1; GDSC2 4.8865 7.8743 2.1796 3.6201
KYAE-1 GDSC1; GDSC2 5.3608 6.8664 2.8297 0.3304
⏷ Show the Full List of 11 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Ascites Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
COLO 684 GDSC1; GDSC2; CTRP2 3.9897 6.9277 3.5112 15.4237
Cancer Drug Sensitivity Data Curated from 36 Cell Line(s) in Autonomic Ganglia Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SJNB-14 GDSC1; GDSC2 -0.3995 1.7158 -0.439 36.237
CHP-134 GDSC2 -0.1844 1.5466 -0.2026 35.2761
MHH-NB-11 GDSC1; GDSC2; CTRP2 0.0902 1.7335 0.0897 39.6696
CHP-212 GDSC1; GDSC2; CTRP2 0.4183 3.1266 0.3929 37.5626
IMR-32 CTRP2 0.5594 3.2439 0.5322 36.6295
NH-12 GDSC1; GDSC2 0.6447 2.5269 0.5726 26.2926
SJNB-10 GDSC1; GDSC2 1.0049 3.2029 0.8247 23.3566
IMR-5 GDSC1; GDSC2 1.0571 2.2014 1.0438 22.0071
KP-N-YS GDSC1; GDSC2 1.1011 2.9568 0.9873 22.085
TGW GDSC1; GDSC2 1.1172 2.6594 1.059 21.6469
SJNB-17 GDSC1; GDSC2 1.2139 2.5824 1.1731 20.6236
CHP-126 GDSC1; GDSC2; CTRP2 1.3525 4.2852 1.2754 31.5147
NB(TU)1 GDSC1; GDSC2 1.3555 3.798 1.0294 20.7402
SJNB-6 GDSC1; GDSC2 1.3619 3.304 1.1877 19.8735
Kelly GDSC1; GDSC2; CTRP2 1.3637 2.6614 1.3633 31.1847
KP-N-RT-BM-1 GDSC2 1.4778 6.8638 -0.1499 27.1249
SJNB-13 GDSC1; GDSC2 1.5335 3.4727 1.327 18.3849
SK-N-DZ GDSC1; GDSC2; CTRP2 1.7113 6.0089 1.3252 30.162
SiMa GDSC1; GDSC2; CTRP2 1.8121 6.1849 1.3864 29.631
NH-6 CTRP2 1.9991 4.901 1.881 27.3502
GOTO GDSC1; GDSC2 2.1066 6.4863 0.6401 19.9571
SK-N-SH GDSC1; GDSC2; CTRP2 2.3833 9.1237 0.9293 29.3034
NB1 GDSC1; CTRP2 2.6052 4.6839 2.5565 23.0767
SK-N-BE(2) CTRP2 3.0332 7.1083 2.4167 22.2654
SJNB-12 GDSC1; GDSC2 3.0371 6.3669 1.556 11.6014
SK-N-FI GDSC1; GDSC2; CTRP2 3.2686 7.9932 2.3262 21.925
SK-N-MC-IXC GDSC1; GDSC2 3.285 5.8003 2.0518 7.8665
SJNB-5 GDSC1; GDSC2 3.4641 6.3019 1.9487 7.9997
NB69 GDSC1; GDSC2 3.5396 6.3062 2.0071 7.4432
KP-N-SI9s CTRP2 3.7452 8.2906 2.699 19.2088
SK-N-BE(2)-M17 GDSC1; GDSC2 3.7773 6.9025 1.8955 7.5143
SJNB-7 GDSC1; GDSC2 3.8417 7.5292 1.6342 8.9209
GI-ME-N GDSC1; GDSC2 4.1572 14.1262 -1.4009 23.0013
SK-N-AS GDSC1; GDSC2; CTRP2 4.298 7.4616 3.626 14.1311
KP-N-YN GDSC1; CTRP2 4.3565 7.9343 3.4836 14.5347
LA-N-6 GDSC1; GDSC2 4.9088 8.0468 2.1144 3.9338
⏷ Show the Full List of 36 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 7 Cell Line(s) in Biliary Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SNU-1079 CTRP2 4.367 5.9791 4.2312 11.6481
HuCC-T1 GDSC1; GDSC2; CTRP2 4.7939 8.3253 3.7466 12.3759
SNU-1196 CTRP2 5.0027 7.6355 4.2731 9.7346
SNU-869 CTRP2 5.4473 10.2434 3.4286 12.1847
SNU-478 CTRP2 6.1884 10.2356 4.0676 8.0322
HuH-28 CTRP2 6.8262 10.5021 4.4288 5.4219
SNU-308 CTRP2 7.1751 10.074 4.876 3.1096
⏷ Show the Full List of 7 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 89 Cell Line(s) in Breast Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
MFM-223 GDSC1; GDSC2 0.1809 5.3252 -0.8039 34.6667
MDA-MB-468 GDSC1; GDSC2; CTRP2 1.3249 4.3587 1.2372 31.7333
DU4475 GDSC1; GDSC2; CTRP2 1.4122 3.5474 1.3958 30.9148
Evsa-T GDSC1; GDSC2 2.1149 4.4733 1.5776 14.6169
Hs 578T GDSC1; GDSC2; CTRP2 2.127 7.1976 1.4068 28.5586
HCC1569 GDSC1; GDSC2 2.5527 7.258 0.681 18.2018
COLO 824 GDSC1; GDSC2 2.7928 5.2852 1.8707 10.4746
OCUB-M GDSC1; GDSC2 2.8727 4.6922 2.2339 8.0288
MDA-MB-157 GDSC1; GDSC2; CTRP2 3.0012 5.6997 2.8106 20.9334
MDA-MB-453 GDSC1; GDSC2; CTRP2 3.1431 5.0432 3.0847 19.5267
HCC2218 GDSC1; GDSC2; CTRP2 3.2003 5.7809 3.0084 19.613
MRK-nu-1 GDSC1; GDSC2 3.322 6.9148 1.5256 10.9514
HCC1599 GDSC2 3.4252 6.4114 1.8624 8.9057
CAL-148 GDSC2; CTRP2 3.4552 7.4466 2.7419 19.8444
HCC70 GDSC1; GDSC2 3.6762 6.8832 1.8272 8.1798
UACC-812 GDSC2 3.7512 6.4015 2.1236 6.4021
HCC1500 GDSC1; GDSC2; CTRP2 3.7744 7.1009 3.2155 17.1536
T-47D GDSC1; GDSC2; CTRP2 3.8073 5.8794 3.646 15.464
CAL-51 GDSC1; GDSC2; CTRP2 3.9148 8.7743 2.66 18.909
MCF-7 GDSC1; GDSC2; CTRP2 3.9518 8.3129 2.9023 17.8742
MDA-MB-436 GDSC1; GDSC2 3.9935 6.9814 2.0173 6.2719
HCC1954 GDSC1; GDSC2 4.0299 6.763 2.1498 5.4032
HCC2157 GDSC1; GDSC2 4.1075 6.1889 2.4784 3.3231
MDA-MB-175-VII GDSC1; GDSC2 4.1447 6.5958 2.3095 4.2242
HCC1395 GDSC1; GDSC2; CTRP2 4.1905 9.6259 2.5445 18.6492
HCC1187 GDSC1; GDSC2 4.4144 11.1486 0.2776 15.0505
BT-483 GDSC1; GDSC2 4.4434 6.9614 2.3303 3.5417
AU565 GDSC1; GDSC2 4.5087 8.7214 1.5358 7.9563
BT-20 GDSC1; GDSC2; CTRP2 4.5166 7.441 3.8626 12.6217
ZR-75-30 GDSC1; GDSC2; CTRP2 4.5328 7.0997 4.0221 11.9561
MDA-MB-231 GDSC1; GDSC2; CTRP2 4.6658 7.9796 3.7779 12.5702
BT-474 GDSC1; GDSC2; CTRP2 4.6658 7.447 4.0144 11.6302
EFM-19 GDSC1; GDSC2 4.7194 10.198 0.9675 10.6918
HCC1419 GDSC1; GDSC2; CTRP2 4.7353 8.4783 3.6175 13.0413
MDA-MB-361 GDSC1; GDSC2; CTRP2 4.7911 6.9944 4.3368 10.0332
CAL-120 GDSC1; GDSC2; CTRP2 4.8354 7.8748 3.996 11.2681
YMB-1-E GDSC2 4.8656 8.5057 1.8758 5.5048
HCC38 GDSC1; GDSC2; CTRP2 4.9703 8.6398 3.7704 11.853
MDA-MB-415 GDSC1; GDSC2 4.9769 9.0076 1.7116 6.0258
HCC1428 GDSC1; GDSC2; CTRP2 5.0778 8.5232 3.9296 10.9479
HCC202 GDSC1; GDSC2; CTRP2 5.4142 11.3412 2.854 14.5916
SK-BR-3 CTRP2 5.5736 6.7871 5.233 4.4434
JIMT-1 GDSC1; GDSC2; CTRP2 5.7424 9.1362 4.2402 8.1867
HCC1143 GDSC1; GDSC2; CTRP2 5.7565 11.4229 3.1116 12.8378
EFM-192A GDSC1; GDSC2; CTRP2 5.9161 10.2649 3.8263 9.5666
CAL-85-1 GDSC1; GDSC2; CTRP2 6.0543 10.3148 3.9174 8.9158
MDA-MB-330 GDSC1; GDSC2 6.3488 8.4408 2.6424 0.3761
Hs 578Bst CTRP2 6.4317 9.8862 4.4359 6.0488
BT-549 GDSC1; GDSC2; CTRP2 6.4342 12.8719 2.9498 12.1729
HDQ-P1 GDSC1; GDSC2; CTRP2 7.2299 11.6478 4.1586 5.9057
HMC-1-8 CTRP2 7.2412 12.6051 3.7001 7.7492
UACC-893 GDSC1; GDSC2 7.8352 17.6643 -0.528 11.9282
ZR-75-1 CTRP2 7.996 9.2801 5.629 0.1356
HCC1806 GDSC1; GDSC2; CTRP2 7.9982 13.7716 2.8275 5.2474
CAMA-1 GDSC1; GDSC2; CTRP2 8.3057 15.9397 2.831 9.5561
HCC1937 GDSC1; GDSC2; CTRP2 8.5887 13.332 4.2391 3.854
BT 440 CTRP2 0.6327 3.0285 0.6176 36.1031
BT 504 CTRP2 2.1051 5.6854 1.8378 27.1587
BT 286 CTRP2 2.7651 6.9185 2.1938 23.8679
BT 145 CTRP2 2.7779 5.2101 2.6678 22.1376
BT 112 CTRP2 2.8986 6.4213 2.5014 22.3558
BT 482 CTRP2 3.0136 5.4169 2.8845 20.6342
BT164 CTRP2 3.0726 6.3529 2.712 21.069
BT 231 CTRP2 3.2749 7.6311 2.478 21.343
BT147 CTRP2 3.3383 11.3843 0.8831 26.7199
BT 139 CTRP2 3.3835 11.2268 1.0013 26.2265
BT 330 CTRP2 3.4108 7.6632 2.6095 20.4674
BT 416 CTRP2 3.4704 7.8133 2.6121 20.2912
BT 428 CTRP2 3.5931 7.7386 2.7718 19.3461
BT 271 CTRP2 3.6994 10.6966 1.5601 23.5298
BT 172 CTRP2 4.0936 8.6072 2.9163 17.4487
BT 187 CTRP2 4.3753 11.383 1.8824 20.6852
BT 340 CTRP2 4.419 10.4332 2.3824 18.7097
BT 333 CTRP2 4.5725 10.0247 2.7254 17.0078
BT 422 CTRP2 4.6506 11.0292 2.3127 18.4237
BT 131 CTRP2 4.6565 8.3345 3.6062 13.2819
BT 228 CTRP2 4.6755 11.7965 1.9607 19.6852
BT 248 CTRP2 4.7847 9.8916 2.9914 15.449
BT 245 CTRP2 4.8238 7.7939 4.0212 11.196
BT 159 CTRP2 4.845 11.124 2.4469 17.4567
BT 444 CTRP2 4.945 10.4294 2.8796 15.5254
BT 232 CTRP2 5.0222 8.7553 3.765 11.7526
BT 216 CTRP2 5.2228 9.9161 3.3874 12.8437
BT 328 CTRP2 5.4922 8.81 4.1782 8.9787
BT 359 CTRP2 5.7835 11.2948 3.1987 12.428
BT 498 CTRP2 5.8361 14.5478 1.6179 18.388
BT 320 CTRP2 5.9166 8.8742 4.5216 6.6515
BT 224 CTRP2 6.2398 12.7883 2.8339 13.0019
BT 179 CTRP2 6.4871 11.342 3.7548 8.7892
⏷ Show the Full List of 89 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Tongue Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
YD-38 CTRP2 7.9477 11.2613 4.7994 2.5041
Cancer Drug Sensitivity Data Curated from 69 Cell Line(s) in Central Nervous System Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
H4 GDSC1; GDSC2 0.3505 2.5695 0.2493 29.2833
D-245MG GDSC2 0.8524 6.0278 -0.3988 30.9228
SF539 GDSC1; GDSC2; CTRP2 1.5472 4.5342 1.4512 30.2822
PFSK-1 GDSC1 1.6075 5.3082 -0.6711 11.0101
42-MG-BA GDSC1; GDSC2; CTRP2 1.6772 8.8884 0.2845 33.3852
MOG-G-CCM GDSC1; GDSC2 1.6925 4.296 1.2076 18.3658
D-423MG GDSC1; GDSC2 1.8657 4.7228 1.2124 17.6521
CAS-1 GDSC1; GDSC2 2.036 5.7212 0.934 18.584
MOG-G-UVW GDSC1; GDSC2 2.0403 5.2079 1.1753 17.1995
D-263MG GDSC1; GDSC2 2.2805 5.3213 1.3617 15.2491
SF126 GDSC1; GDSC2; CTRP2 2.4981 6.726 1.9688 25.4769
D283 Med GDSC1; GDSC2; CTRP2 2.5054 7.9214 1.5459 26.9266
A-172 GDSC1; GDSC2; CTRP2 2.6858 6.2746 2.3137 23.6768
M059J GDSC1; GDSC2 2.7323 5.1847 1.8628 10.7228
GI-1 GDSC1; GDSC2 2.8233 6.8644 1.1197 14.8441
D-392MG GDSC1; GDSC2 2.8514 11.2273 -1.0294 25.2622
SNU-201 CTRP2 3.1486 5.5831 2.9971 19.8139
LNZTA3WT4 GDSC1; GDSC2 3.1927 8.7709 0.489 17.2424
SNU-1105 CTRP2 3.2108 5.5057 3.0807 19.3247
D-247MG GDSC1; GDSC2 3.3125 7.3521 1.299 12.3265
KNS-60 CTRP2 3.3597 8.608 2.1636 22.2726
CCF-STTG1 CTRP2 3.4192 9.777 1.7067 23.7609
TM-31 CTRP2 3.4333 13.1489 0.1356 28.6507
D-502MG GDSC1; GDSC2 3.4389 7.8754 1.1419 12.8899
YH-13 GDSC1; GDSC2; CTRP2 3.6442 15.1992 -0.6603 30.1359
D-566MG GDSC1; GDSC2 3.6845 7.7412 1.4067 10.6735
SNU-738 CTRP2 3.6962 8.5465 2.5374 19.9576
D-336MG GDSC1; GDSC2 3.7132 6.0201 2.2834 5.3302
SK-MG-1 GDSC1; GDSC2 3.8131 8.0694 1.344 10.7093
KNS-81-FD GDSC1; GDSC2 3.9195 6.6115 2.1446 5.6809
8-MG-BA GDSC1; GDSC2; CTRP2 3.9582 9.1748 2.5226 19.3244
Onda 10 GDSC1; GDSC2 3.9687 5.7563 2.5924 2.9375
LN-405 GDSC1; GDSC2 4.0267 6.4793 2.285 4.6116
KS-1 [Human Krukenberg tumour] GDSC1; GDSC2 4.0497 8.0676 1.525 9.0606
SF268 GDSC1; GDSC2; CTRP2 4.0739 6.8499 3.6305 14.7334
AM-38 GDSC1; GDSC2; CTRP2 4.099 6.7571 3.6915 14.4312
SW1088 GDSC1; GDSC2; CTRP2 4.2511 8.1173 3.295 15.5528
Hs 683 GDSC1; GDSC2; CTRP2 4.2934 8.0622 3.3626 15.1765
D-542MG GDSC1; GDSC2 4.3096 10.2849 0.6254 13.5014
SNU-489 CTRP2 4.3526 6.6132 4.0166 12.4812
GaMG GDSC1; GDSC2; CTRP2 4.5997 8.3311 3.5511 13.6448
GB-1 GDSC1; GDSC2; CTRP2 4.6181 8.1679 3.6442 13.2257
ONS-76 GDSC1; GDSC2; CTRP2 4.6898 9.0666 3.296 14.4495
U-118MG GDSC1; GDSC2; CTRP2 4.7516 9.5976 3.1018 15.0839
M059K CTRP2 4.7601 13.0054 1.4431 21.3347
T98G GDSC1; GDSC2; CTRP2 4.8905 9.6191 3.2233 14.2678
KALS-1 GDSC1; GDSC2; CTRP2 4.9046 8.7751 3.6425 12.5305
SW1783 GDSC1; GDSC2; CTRP2 5.07 8.536 3.916 11.022
YKG-1 GDSC1; GDSC2; CTRP2 5.0748 9.8383 3.2891 13.5773
SNB-75 GDSC1; GDSC2; CTRP2 5.2906 7.2126 4.755 7.075
DK-MG GDSC1; GDSC2; CTRP2 5.3702 17.2302 -0.1199 24.801
SNU-626 CTRP2 5.4016 11.9105 2.5598 15.7829
Daoy GDSC1; GDSC2; CTRP2 5.4023 9.7313 3.6418 11.4017
DBTRG-05MG GDSC1; GDSC2; CTRP2 5.4914 8.2313 4.4617 7.8031
SF295 GDSC1; GDSC2; CTRP2 5.5199 11.7377 2.7496 14.7835
KG-1-C CTRP2 5.5885 7.7012 4.811 6.1371
KINGS-1 GDSC1; GDSC2 5.6297 8.2453 2.4141 1.5502
Onda 11 GDSC1; GDSC2 5.8137 8.0438 2.5757 0.81
Becker GDSC1; GDSC2; CTRP2 5.8326 10.2362 3.7695 9.9709
U-251MG GDSC1; GDSC2; CTRP2 5.9901 10.5583 3.742 9.7728
NMC-G1 GDSC1; GDSC2; CTRP2 6.0088 8.2396 4.917 4.8081
KNS-42 GDSC1; GDSC2; CTRP2 6.1295 12.3524 2.961 12.7059
SNU-466 CTRP2 6.1417 9.3099 4.492 6.3395
LN-18 GDSC1; GDSC2; CTRP2 6.3239 8.8236 4.8803 4.3796
KNS-81 CTRP2 6.8874 12.4372 3.5205 9.0574
LN-229 GDSC1; GDSC2; CTRP2 7.3039 9.5474 5.1978 1.739
U-87MG ATCC GDSC1; GDSC2; CTRP2 7.5033 11.4785 4.4258 4.4479
GMS-10 CTRP2 7.5203 16.1067 2.1841 13.2105
GOS-3 CTRP2 8.2116 19.2206 1.1636 15.6271
⏷ Show the Full List of 69 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 3 Cell Line(s) in Digestive System Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
TGBC24TKB GDSC1; GDSC2 1.7242 5.2553 0.834 20.3126
ETK-1 GDSC1; GDSC2 3.2873 6.8235 1.5422 10.9503
TGBC1TKB GDSC1; GDSC2 3.8474 5.6234 2.5742 3.2892
Cancer Drug Sensitivity Data Curated from 23 Cell Line(s) in Endometrium Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
JHUEM-2 CTRP2 -0.6022 2.2111 -0.6164 44.3156
AN3-CA GDSC1; GDSC2; CTRP2 1.4417 7.5212 0.5526 33.4387
JHUEM-7 CTRP2 2.6174 6.2606 2.2432 24.1374
ESS-1 GDSC1; GDSC2; CTRP2 2.8365 5.9485 2.5692 22.3015
JHUEM-1 CTRP2 3.4079 5.646 3.2653 18.0563
MFE-296 GDSC1; GDSC2; CTRP2 3.5018 7.1161 2.9177 19.051
RL95-2 GDSC1; GDSC2; CTRP2 3.6593 8.0336 2.7192 19.3645
HEC-59 CTRP2 4.2925 11.2675 1.86 20.9676
HEC-1-A CTRP2 4.3823 6.4158 4.117 12.0202
HEC-151 CTRP2 4.4493 6.3254 4.2195 11.4435
MFE-280 GDSC1; GDSC2 4.5303 7.9991 1.8976 5.8313
EN GDSC1; GDSC2; CTRP2 4.5908 11.7139 1.9227 20.0234
MFE-319 GDSC1; GDSC2; CTRP2 4.9483 7.0008 4.4984 8.9798
JHUEM-3 CTRP2 6.1979 7.7769 5.3025 2.8344
EFE-184 CTRP2 6.2128 9.4346 4.4875 6.2263
HEC-50B CTRP2 6.2799 12.3938 3.0637 12.0046
KLE GDSC1; GDSC2; CTRP2 6.3545 10.0538 4.2919 6.7878
HEC-1-B CTRP2 7.347 12.6097 3.7738 7.2868
HEC-6 CTRP2 7.8398 10.9012 4.8987 2.2599
HEC-265 CTRP2 7.95 9.2686 5.616 0.1636
HEC-108 CTRP2 8.3283 17.2002 2.2362 11.7312
HEC-251 CTRP2 8.7478 14.1579 3.9579 4.7094
Ishikawa (Heraklio) 02 ER- CTRP2 7.6127 8.5141 5.7555 0.0592
⏷ Show the Full List of 23 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 40 Cell Line(s) in Kidney Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
A-704 GDSC1; GDSC2 3.0534 6.6881 1.4101 12.4256
KTCTL-13 GDSC1; GDSC2 3.2979 7.0537 1.4359 11.5558
SW13 GDSC1; GDSC2 3.5058 6.1622 2.052 7.2596
NCC010 GDSC1; GDSC2 3.5712 7.0904 1.6412 9.5738
TUHR14TKB CTRP2 3.5809 9.7881 1.8641 22.7661
RXF 393L GDSC1; GDSC2 3.7129 6.8739 1.8603 7.8873
KTCTL-195 GDSC1; GDSC2 3.772 7.1799 1.754 8.3787
LB996-RCC GDSC2 3.8224 7.6757 1.5467 9.8211
SN12C GDSC1; GDSC2 3.9744 6.8512 2.0671 6.0189
786-O GDSC1; GDSC2; CTRP2 4.1339 7.2296 3.5483 14.8792
KTCTL-140 GDSC1; GDSC2 4.1657 10.8544 0.2337 15.8941
TUHR4TKB CTRP2 4.2793 8.4741 3.1641 15.9968
BFTC-909 GDSC1; GDSC2; CTRP2 4.3383 7.8372 3.5074 14.4886
LB2241-RCC GDSC1; GDSC2 4.3822 7.9355 1.8278 6.537
KMRC-2 CTRP2 4.4373 8.0669 3.5072 14.2323
KTCTL-21 GDSC1; GDSC2 4.4765 8.2657 1.7335 6.8856
UO-31 GDSC1; GDSC2; CTRP2 4.5689 7.3764 3.9444 12.1614
BB65-RCC GDSC1; GDSC2 4.58 9.9863 0.9712 10.985
HA7-RCC GDSC1; GDSC2 4.6362 8.4531 1.7517 6.4547
SW156 GDSC1; GDSC2 4.8708 8.5861 1.8415 5.4988
TK-10 GDSC1; GDSC2 4.9492 7.0649 2.5695 1.5796
KTCTL-26A GDSC1; GDSC2 4.9668 11.508 0.5056 12.5971
CAL-54 GDSC1; GDSC2; CTRP2 5.1207 9.184 3.6512 11.9908
KMRC-20 GDSC1; GDSC2; CTRP2 5.1848 8.815 3.8906 10.859
NCC021 GDSC1; GDSC2 5.2262 10.0169 1.3972 7.2932
KTCTL-1M GDSC1; GDSC2 5.2951 9.6619 1.6065 6.0296
LB1047-RCC GDSC1; GDSC2 5.3143 12.5736 0.2329 13.2075
KMRC-3 CTRP2 5.9425 9.653 4.1545 8.1414
769-P GDSC1; GDSC2 6.0144 13.3123 0.353 11.2022
RCC10RGB GDSC1; GDSC2; CTRP2 6.3046 9.8508 4.3534 6.6203
ACHN GDSC1; GDSC2; CTRP2 6.3098 11.7725 3.3984 10.5847
TUHR10TKB CTRP2 6.5329 8.4278 5.2312 5.5455
KMRC-1 GDSC1; GDSC2; CTRP2 6.586 12.6914 3.1608 11.0467
A-498 GDSC1; GDSC2; CTRP2 6.8263 10.7829 4.291 5.9894
VMRC-RCZ GDSC1; GDSC2; CTRP2 6.9586 13.0091 3.2915 9.8662
Caki-2 CTRP2 7.0437 13.7851 2.972 10.999
Caki-1 GDSC1; GDSC2; CTRP2 7.4962 13.8815 3.2601 9.1144
VMRC-RCW GDSC1; GDSC2; CTRP2 7.5021 12.5996 3.8878 6.5951
OS-RC-2 GDSC1; GDSC2; CTRP2 7.8954 14.2441 3.3659 8.0919
SNU-1272 CTRP2 7.9624 13.8454 3.6034 7.0636
⏷ Show the Full List of 40 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 57 Cell Line(s) in Large Intestine Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
NCI-H716 GDSC1; GDSC2; CTRP2 -2.0897 1.4768 -2.1111 54.1068
SNU-175 GDSC2 1.2051 3.31 1.015 22.2409
SW948 GDSC1; GDSC2; CTRP2 1.5063 2.9374 1.5051 30.2375
NCI-H508 GDSC1; GDSC2; CTRP2 1.9925 6.2388 1.5679 28.4421
SW48 GDSC1; GDSC2; CTRP2 2.0487 5.1651 1.8885 27.1644
GP2d CTRP2 2.1078 4.8834 2.0005 26.5897
COLO205 GDSC1; GDSC2; CTRP2 2.2496 4.0873 2.2319 25.3409
CL-11 GDSC1; GDSC2; CTRP2 2.5437 5.8256 2.2815 24.2294
CaR-1 GDSC1; GDSC2 2.8218 5.5158 1.7847 10.8971
KM12 GDSC1; GDSC2; CTRP2 2.934 6.6182 2.4776 22.3361
SNU-407 GDSC1; GDSC2; CTRP2 3.5099 5.9031 3.3157 17.5607
GP5d GDSC1; GDSC2 3.5146 8.2989 0.9921 13.5413
SW1463 GDSC1; GDSC2 3.8414 6.9592 1.9159 7.2353
SNU-81 GDSC1; GDSC2 3.8441 6.5952 2.0975 6.1384
SW620 GDSC1; GDSC2; CTRP2 3.9473 6.371 3.6589 14.9945
LoVo GDSC1; GDSC2; CTRP2 4.0859 8.2694 3.0589 16.9112
LS513 GDSC1; GDSC2; CTRP2 4.124 7.8098 3.2977 15.8777
COLO 320HSR GDSC1; GDSC2 4.1669 8.4796 1.409 9.4603
SW1116 GDSC1; GDSC2 4.1997 6.4026 2.4373 3.3829
RKO GDSC1; GDSC2; CTRP2 4.3471 6.5618 4.0289 12.4508
LS123 GDSC1; GDSC2; CTRP2 4.3971 6.6759 4.0418 12.2589
SNU-61 GDSC1; GDSC2; CTRP2 4.4188 6.8643 3.9944 12.3774
T84 GDSC1; GDSC2; CTRP2 4.4512 6.5538 4.1441 11.7186
SW837 GDSC1; GDSC2 4.6007 6.9016 2.4521 2.6214
SNU-C1 GDSC1; GDSC2; CTRP2 4.7121 6.7661 4.345 10.218
SNU-C5 GDSC1; GDSC2; CTRP2 4.7533 7.8857 3.9086 11.8254
DiFi GDSC1; GDSC2 4.8942 11.4016 0.5057 12.7586
SK-CO-1 GDSC1; GDSC2; CTRP2 4.9421 9.7064 3.2296 14.1228
HT115 GDSC1; GDSC2; CTRP2 4.9898 9.697 3.2788 13.813
SW626 GDSC1; GDSC2 5.0158 7.5785 2.3844 2.3757
SNU-C2B GDSC1; GDSC2 5.3166 8.4956 2.1475 3.1463
SNU-C4 CTRP2 5.3247 6.1325 5.2333 5.1181
NCI-H747 GDSC1; GDSC2; CTRP2 5.3306 8.5699 4.1467 9.4697
SNU-283 GDSC2 5.3813 7.0922 2.755 0.5362
SW1417 GDSC1; GDSC2; CTRP2 5.4372 8.3687 4.3442 8.4115
DLD-1 CTRP2 5.4795 9.2109 3.9688 9.8773
LS1034 GDSC1; GDSC2; CTRP2 5.5547 8.0273 4.6201 7.0041
COLO201 CTRP2 5.7497 9.2041 4.2127 8.2865
HCT 8 CTRP2 5.8503 7.0219 5.3857 3.1674
HCC-56 CTRP2 5.9141 6.4504 5.7247 1.6182
RCM-1 [Human ESC] GDSC1; GDSC2; CTRP2 5.9887 6.9478 5.5455 2.207
SNU-503 CTRP2 6.0461 9.6278 4.2542 7.5205
HCC2998 GDSC1; GDSC2 6.1589 7.8431 2.7812 0.1812
SNU-1033 CTRP2 6.231 10.7571 3.8417 8.8964
COLO 678 GDSC1; GDSC2; CTRP2 6.2673 10.5089 3.9951 8.1885
HCT 15 GDSC1; GDSC2; CTRP2 6.5426 12.4158 3.2638 10.7074
CCK-81 GDSC1; GDSC2; CTRP2 6.6121 10.4216 4.309 6.268
HT-55 GDSC1; GDSC2; CTRP2 6.8492 12.0176 3.6991 8.391
C2BBe1 GDSC1; GDSC2; CTRP2 6.854 14.3647 2.5382 13.0259
OUMS-23 CTRP2 7.0491 9.6257 5.0058 2.7643
LS411N GDSC1; GDSC2; CTRP2 7.2929 8.9378 5.458 0.862
LS180 GDSC1; GDSC2; CTRP2 7.6207 11.4988 4.4923 4.0339
CW-2 GDSC1; GDSC2; CTRP2 7.7446 11.2927 4.6654 3.2197
SNU-C2A CTRP2 7.7624 15.3522 2.733 10.7521
MDST8 GDSC1; GDSC2; CTRP2 7.7964 10.3529 5.1155 1.5531
HT-29 GDSC1; GDSC2; CTRP2 7.9399 9.4307 5.5537 0.2685
HCT 116 GDSC1; GDSC2; CTRP2 7.967 9.1539 5.6623 0.101
⏷ Show the Full List of 57 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Leukemia Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
MO-T GDSC1; GDSC2 3.4028 7.6044 1.2477 12.3732
Cancer Drug Sensitivity Data Curated from 26 Cell Line(s) in Liver Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SNU-886 CTRP2 0.8289 5.27 0.5438 35.6243
Li-7 CTRP2 2.0377 10.1085 0.1498 32.5871
SNU-878 CTRP2 2.5081 5.5894 2.2991 24.2788
JHH-7 GDSC1; GDSC2 2.7632 5.805 1.5887 12.2629
Huh-7 GDSC1; GDSC2 2.9059 7.584 0.835 16.2152
HuH-6 CTRP2 3.0544 7.1671 2.4181 22.1985
JHH-5 CTRP2 3.1071 6.0358 2.8411 20.4979
Hep 3B2.1-7 GDSC1; GDSC2; CTRP2 3.286 9.47 1.7101 24.1119
Hep-G2/C3A GDSC1; GDSC2 3.9784 6.0404 2.4632 3.6671
HLE GDSC1; GDSC2 3.9791 9.6165 0.7041 13.9076
HuH-1 GDSC1; GDSC2; CTRP2 4.016 12.4058 1.0476 24.4411
JHH-4 GDSC1; GDSC2; CTRP2 4.2244 7.5671 3.505 14.8004
SNU-182 CTRP2 4.3614 7.6133 3.628 13.9539
JHH-2 GDSC1; GDSC2; CTRP2 4.4555 6.3769 4.2094 11.4624
SNU-398 GDSC1; GDSC2; CTRP2 4.533 10.4627 2.4767 18.0726
SK-HEP-1 GDSC1; GDSC2; CTRP2 4.5651 7.1595 4.0314 11.8323
SNU-761 CTRP2 4.6016 8.4152 3.5143 13.7875
PLC/PRF/5 CTRP2 4.6218 7.9447 3.7491 12.7969
SNU-475 CTRP2 4.666 7.3358 4.0625 11.4404
SNU-387 GDSC1; GDSC2; CTRP2 4.6851 7.4656 4.0262 11.5327
JHH-1 GDSC1; GDSC2; CTRP2 5.3555 9.262 3.8307 10.722
SNU-449 GDSC1; GDSC2; CTRP2 5.4016 10.6865 3.168 13.3505
HLF CTRP2 5.425 9.4047 3.8237 10.5988
JHH-6 GDSC1; GDSC2; CTRP2 6.0581 6.7649 5.6955 1.4402
SNU-423 GDSC1; GDSC2; CTRP2 6.1375 11.7438 3.2719 11.4298
Hep-G2 CTRP2 6.8289 12.3331 3.5275 9.1279
⏷ Show the Full List of 26 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 222 Cell Line(s) in Lung Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
NCI-H1703 GDSC1; GDSC2; CTRP2 -4.9904 19.1706 -11.0378 57.6685
SBC-3 GDSC1; GDSC2 0.5455 2.4839 0.4727 27.2564
A-427 GDSC1; GDSC2 0.6324 4.3546 0.0518 28.9288
LB647-SCLC GDSC1; GDSC2 0.6387 2.7824 0.5214 26.5767
IST-SL1 GDSC1; GDSC2 0.6428 2.1772 0.6133 26.1
NCI-H1581 GDSC1; GDSC2; CTRP2 0.7441 4.3316 0.6217 35.6983
LK-2 GDSC1; GDSC2 0.8097 3.4132 0.5547 25.6245
NCI-H2227 GDSC1; GDSC2 0.8942 1.8855 0.8901 23.5399
NCI-H2171 GDSC2 0.9327 2.4387 0.8919 24.1838
NCI-H446 GDSC1; GDSC2; CTRP2 0.9402 3.2061 0.9257 34.0526
NCI-H847 GDSC1; GDSC2 0.955 2.2194 0.9365 23.0214
NCI-H524 GDSC1; GDSC2 1.0058 2.4837 0.9642 22.6433
NCI-H1048 GDSC1; GDSC2 1.0227 2.6381 0.9609 22.5806
NCI-H1963 GDSC1; GDSC2 1.0734 2.5609 1.0262 22.0164
NCI-H1876 GDSC1; GDSC2 1.0896 2.5891 1.0396 21.8738
NCI-H510A GDSC1; GDSC2; CTRP2 1.1172 4.7437 0.9583 33.3432
UMC-11 GDSC1; GDSC2 1.1901 3.1977 1.0281 21.4721
Lu-135 GDSC1; GDSC2 1.1949 3.1819 1.0374 21.4021
LC-2/ad GDSC1; GDSC2 1.4045 4.2099 0.9341 21.0468
NCI-H720 GDSC1; GDSC2 1.4642 4.1609 1.0165 20.3511
NCI-H209 GDSC1; GDSC2 1.4864 5.041 0.683 22.0702
SBC-1 GDSC1; GDSC2 1.5348 3.4239 1.3428 18.2949
NCI-H82 GDSC1; GDSC2 1.5761 4.1691 1.1331 19.2517
NCI-H2795 GDSC1; GDSC2 1.617 5.7057 0.5232 22.4089
NCI-H1436 GDSC1; GDSC2 1.689 3.7097 1.4207 17.2131
NCI-H211 GDSC1; GDSC2; CTRP2 1.7154 5.1599 1.5288 29.4692
NCI-H2081 GDSC1; GDSC2; CTRP2 1.8168 4.6671 1.7207 28.4887
NCI-H1341 GDSC1; GDSC2; CTRP2 1.8446 5.1096 1.6782 28.5425
NCI-H2731 GDSC1; GDSC2 1.9055 5.2496 1.0206 18.5814
NCI-H187 GDSC1 1.9437 3.7048 0.3296 2.6905
VMRC-LCD GDSC1; GDSC2; CTRP2 1.9762 4.5399 1.9069 27.3363
HARA [Human squamous cell lung carcinoma] GDSC1; GDSC2; CTRP2 2.0129 4.1548 1.9822 26.9613
COR-L311 GDSC2 2.1744 6.4707 0.7124 19.9768
NCI-H748 GDSC2 2.1843 6.7661 0.5794 20.6802
NCI-H1105 GDSC1; GDSC2; CTRP2 2.2615 5.425 2.0671 25.8677
NCI-H1770 GDSC1; GDSC2 2.291 4.9851 1.5283 14.2421
HCC15 GDSC1; GDSC2; CTRP2 2.3674 5.1049 2.2435 24.919
Ms-1 GDSC1; GDSC2 2.4154 4.5188 1.8657 11.8219
HCC95 CTRP2 2.4363 6.125 2.0845 25.2584
HCC44 GDSC1; GDSC2; CTRP2 2.4551 5.0265 2.3509 24.2667
NCI-H810 GDSC1; GDSC2; CTRP2 2.4683 5.8078 2.2037 24.7389
NCI-H1155 GDSC1; GDSC2; CTRP2 2.4936 6.1749 2.1329 24.9102
NCI-H1385 CTRP2 2.561 4.2895 2.5425 23.2688
COR-L279 GDSC1; GDSC2 2.5697 4.816 1.8826 11.1642
NCI-H1694 GDSC1; GDSC2; CTRP2 2.5818 6.1733 2.2296 24.2953
EMC-BAC-2 GDSC1; GDSC2 2.6087 6.3043 1.2014 15.0593
COR-L321 GDSC1; GDSC2 2.6188 4.8591 1.9102 10.8282
DV-90 CTRP2 2.6387 6.8843 2.0686 24.6961
NCI-H841 GDSC1; GDSC2; CTRP2 2.6608 7.8513 1.7386 25.7975
DMS 273 GDSC1; GDSC2; CTRP2 2.7498 6.7258 2.2422 23.7394
NCI-H1184 CTRP2 2.7905 6.2138 2.4457 22.8842
CPC-N GDSC1; GDSC2 2.8345 6.0321 1.5419 12.3145
NCI-H2286 CTRP2 2.8551 5.5049 2.6949 21.7987
NCI-H69 GDSC1; GDSC2; CTRP2 2.8998 7.0012 2.3108 23.0446
Lu-139 GDSC1; GDSC2 2.956 4.7484 2.2847 7.4477
LXF 289 GDSC1; GDSC2; CTRP2 3.0122 6.1878 2.6951 21.3127
ABC-1 GDSC1; GDSC2 3.1272 9.8847 -0.1231 20.5242
HCC33 GDSC2 3.163 5.8806 1.9079 9.4216
COR-L51 CTRP2 3.1887 5.34 3.0881 19.369
NCI-H250 GDSC2 3.2272 9.1301 0.3385 18.491
COR-L32 GDSC2 3.3111 6.4876 1.7301 10.0952
NCI-H146 GDSC1; GDSC2 3.332 5.792 2.0953 7.4684
Lu-134-A GDSC1; GDSC2 3.3776 6.3704 1.8439 8.8731
DMS 53 GDSC1; GDSC2; CTRP2 3.3827 6.1406 3.1128 18.6793
NCI-H889 CTRP2 3.4358 6.1296 3.1739 18.2974
NCI-H2009 GDSC1; GDSC2; CTRP2 3.4449 6.6578 3.0191 18.8376
NCI-H290 GDSC1; GDSC2 3.4755 7.5416 1.3386 11.6367
NCI-H1688 GDSC1; GDSC2 3.4958 6.37 1.9402 7.966
NCI-H2106 CTRP2 3.4976 6.8365 3.0145 18.7009
NCI-H2141 GDSC1; GDSC2; CTRP2 3.5443 6.8334 3.066 18.3738
NCI-H23 GDSC1; GDSC2; CTRP2 3.5476 7.2394 2.9204 18.9107
NCI-H64 GDSC1; GDSC2 3.5641 7.0726 1.6444 9.5738
NCI-H835 GDSC1; GDSC2 3.5893 7.4711 1.4658 10.5748
NCI-H1304 GDSC1 3.5947 4.8951 0.5861 0.0917
DMS 454 CTRP2 3.6375 6.6585 3.2276 17.501
LC-1F CTRP2 3.6444 9.4433 2.085 21.7925
NCI-H2373 GDSC1; GDSC2 3.6487 12.5341 -1.0148 22.887
COR-L23 GDSC1; GDSC2 3.6597 6.425 2.0421 6.9224
NCI-H520 GDSC1; GDSC2; CTRP2 3.6744 8.1382 2.6907 19.4319
NCI-H2196 GDSC2; CTRP2 3.6881 7.4045 3.0061 18.1909
Lu-99A GDSC1; GDSC2 3.7468 6.0732 2.2823 5.2568
PC-14 GDSC1; GDSC2; CTRP2 3.7527 7.1041 3.1911 17.3072
NCI-H2591 GDSC1; GDSC2 3.7611 6.2353 2.2131 5.6396
NCI-H2135 GDSC1; GDSC2 3.7629 6.2601 2.2022 5.701
NCI-H1755 GDSC1; GDSC2; CTRP2 3.7634 6.633 3.3727 16.594
NCI-H596 GDSC1; GDSC2 3.7755 7.168 1.7626 8.3179
NCI-H1781 GDSC1; GDSC2 3.7957 6.3087 2.2026 5.6207
NCI-H2810 GDSC1; GDSC2 3.7971 9.5172 0.6108 14.8896
Lu-99 CTRP2 3.7992 6.6264 3.4138 16.337
NCI-H1092 GDSC1; GDSC2; CTRP2 3.7993 6.6014 3.4223 16.3051
NCI-H1975 GDSC1; GDSC2 3.8011 7.6527 1.5418 9.5727
NCI-H2347 GDSC1; GDSC2 3.8048 6.2198 2.253 5.2963
NCI-H2110 GDSC1; GDSC2; CTRP2 3.8093 7.7619 2.9894 17.9202
NCI-H2461 GDSC1; GDSC2 3.8574 8.3605 1.2338 11.2388
NCI-H2803 GDSC1; GDSC2 3.8722 7.984 1.4321 10.042
COLO 668 GDSC1; GDSC2; CTRP2 3.8902 6.6259 3.5124 15.7047
COR-L303 GDSC2 3.8991 6.7378 2.0679 6.4072
NCI-H2722 GDSC1; GDSC2 3.9036 7.3641 1.7627 8.0024
RERF-LC-KJ GDSC1; GDSC2 3.9207 6.9922 1.9587 6.7899
NCI-H2804 GDSC1; GDSC2 3.969 7.5321 1.7287 8.048
LCLC-97TM1 GDSC1; GDSC2; CTRP2 3.9952 8.4913 2.8681 17.893
NCI-H1993 GDSC1; GDSC2 4.0113 6.9196 2.0602 5.9763
NCI-H2066 GDSC1; GDSC2 4.0216 7.4161 1.8246 7.3536
NCI-H1437 GDSC1; GDSC2 4.0414 7.5209 1.7877 7.5273
LC-1/sq GDSC1; GDSC2 4.0416 10.5396 0.2939 15.9078
EBC-1 GDSC1; GDSC2; CTRP2 4.0504 6.7715 3.634 14.7871
NCI-H2085 GDSC1; GDSC2; CTRP2 4.0575 9.2662 2.58 18.8487
NCI-H1563 GDSC1; GDSC2; CTRP2 4.0612 6.317 3.7999 14.1378
Lu-165 GDSC1; GDSC2 4.1225 7.8992 1.6613 8.0865
Calu-3 GDSC1; GDSC2; CTRP2 4.1798 7.2808 3.5763 14.6448
HCC1588 CTRP2 4.1962 8.3321 3.1437 16.2914
RERF-LC-MS GDSC1; GDSC2; CTRP2 4.2036 7.2721 3.6048 14.4697
NCI-H1836 GDSC1; GDSC2 4.2143 7.0294 2.1488 5.0173
SW1573 GDSC1; GDSC2 4.2327 8.5384 1.4283 9.1941
COR-L95 GDSC1; GDSC2; CTRP2 4.2641 6.5797 3.9329 13.0503
EMC-BAC-1 GDSC1; GDSC2 4.3098 10.2089 0.663 13.2995
SBC-5 GDSC1; GDSC2; CTRP2 4.3125 7.9074 3.4502 14.7817
HOP-92 GDSC1; GDSC2; CTRP2 4.3176 7.6184 3.5803 14.2571
DMS 79 GDSC1; GDSC2; CTRP2 4.3441 7.8142 3.5233 14.4108
Lu-65 GDSC1; GDSC2; CTRP2 4.3583 6.8644 3.9297 12.794
CAL-12T GDSC1; GDSC2; CTRP2 4.3788 8.0132 3.4715 14.5248
EPLC-272H GDSC1; GDSC2; CTRP2 4.382 7.3749 3.7502 13.4213
NCI-H3255 GDSC1; GDSC2 4.3863 6.2693 2.6124 2.1062
NCI-H2172 GDSC1; GDSC2; CTRP2 4.3882 7.5718 3.6734 13.7046
NCI-H2228 GDSC1; GDSC2; CTRP2 4.4287 8.7652 3.1806 15.5535
LK2 CTRP2 4.4292 7.4029 3.7878 13.1477
NCI-H661 GDSC1; GDSC2; CTRP2 4.4307 8.5379 3.2873 15.1235
RERF-LC-A1 CTRP2 4.4444 7.7996 3.6328 13.7165
IST-SL2 GDSC1; GDSC2 4.4688 10.0996 0.8349 11.9893
NCI-H3122 GDSC1; GDSC2 4.4874 8.2066 1.7694 6.6558
NCI-H1373 CTRP2 4.5017 6.396 4.2532 11.1649
HCC2279 CTRP2 4.5077 6.478 4.2317 11.2275
HCC1195 CTRP2 4.5177 7.3128 3.9179 12.402
NCI-H2595 GDSC1; GDSC2 4.5184 9.1602 1.3298 9.1133
COR-L88 GDSC1; GDSC2; CTRP2 4.5194 7.4249 3.8723 12.576
NCI-H1650 GDSC1; GDSC2; CTRP2 4.5209 7.2935 3.9294 12.3486
NCI-H513 GDSC1; GDSC2 4.5215 6.7899 2.4563 2.7225
NCI-H2029 GDSC1; GDSC2; CTRP2 4.5287 10.1563 2.6203 17.525
NCI-H838 GDSC1; GDSC2; CTRP2 4.5408 7.6277 3.807 12.7766
SW1271 GDSC1; GDSC2; CTRP2 4.561 6.6134 4.241 11.0395
PaCa-3 GDSC1; GDSC2 4.596 6.9095 2.4458 2.6619
NCI-H1944 GDSC1; GDSC2; CTRP2 4.6355 9.7055 2.9389 16.0117
SHP-77 GDSC1; GDSC2; CTRP2 4.6403 7.7791 3.8421 12.3793
NCI-H345 GDSC1; GDSC2 4.682 5.7011 2.9882 0.2332
HCC1438 CTRP2 4.6831 7.3025 4.0945 11.2694
NCI-H522 GDSC2; CTRP2 4.6877 8.8222 3.4095 13.9969
HCC366 GDSC1; GDSC2; CTRP2 4.7118 8.5107 3.5792 13.2536
NCI-H1648 GDSC1; GDSC2 4.7132 8.4922 1.784 6.1192
NCI-H1355 GDSC1; GDSC2; CTRP2 4.7599 8.0317 3.8486 12.0498
NCI-H647 GDSC1; GDSC2; CTRP2 4.7881 8.427 3.6935 12.6048
RERF-LC-Sq1 GDSC1; GDSC2 4.7946 11.3442 0.4621 13.2085
NCI-H1339 CTRP2 4.8347 8.748 3.5877 12.9206
ChaGo-K-1 GDSC1; GDSC2; CTRP2 4.8359 8.0555 3.9135 11.5985
NCI-H322M GDSC1; GDSC2 4.8444 8.3529 1.9337 5.0338
NCI-H226 GDSC1; GDSC2; CTRP2 4.8852 8.2961 3.8502 11.7332
NCI-H2087 GDSC1; GDSC2; CTRP2 4.8968 7.4754 4.2385 10.1417
NCI-H1792 GDSC1; GDSC2; CTRP2 4.9144 8.642 3.7153 12.2108
NCI-H1568 GDSC1; GDSC2; CTRP2 4.9645 11.0201 2.6078 16.5577
LOU-NH91 GDSC1; GDSC2; CTRP2 5.0106 8.18 4.0276 10.7085
DMS 114 GDSC1; GDSC2; CTRP2 5.024 10.4129 2.9607 15.0213
COR-L105 GDSC1; GDSC2; CTRP2 5.0411 11.1225 2.6274 16.308
SK-MES-1 GDSC1; GDSC2; CTRP2 5.0433 7.7432 4.264 9.6701
NCI-H2122 GDSC1; GDSC2; CTRP2 5.0768 9.5754 3.4194 13.041
IA-LM GDSC1; GDSC2; CTRP2 5.0842 7.7861 4.2846 9.4861
NCI-H2405 GDSC1; GDSC2; CTRP2 5.0856 9.5346 3.4475 12.906
NCI-H1573 GDSC1; GDSC2; CTRP2 5.087 7.7645 4.2974 9.427
HCC4006 CTRP2 5.0925 9.0412 3.6939 11.8803
NCI-H1693 GDSC1; GDSC2; CTRP2 5.099 8.5532 3.9356 10.8737
NCI-H358 GDSC1; GDSC2; CTRP2 5.1216 10.13 3.1895 13.8773
NCI-H1793 GDSC1; GDSC2 5.1447 6.9595 2.7052 0.8355
NCI-H2869 GDSC1; GDSC2 5.1593 11.1926 0.7926 10.6849
NCI-H1915 GDSC1; GDSC2; CTRP2 5.2127 8.2949 4.1682 9.6529
NCI-H740 GDSC2 5.2171 8.2609 2.1957 3.1502
NCI-H1666 GDSC1; GDSC2; CTRP2 5.232 9.7401 3.4824 12.4336
SK-LU-1 GDSC1; GDSC2; CTRP2 5.3499 9.5522 3.6827 11.3472
KNS-62 GDSC1; GDSC2; CTRP2 5.362 7.6936 4.5996 7.5324
NCI-H2818 GDSC1; GDSC2 5.3908 23.3606 -5.0298 29.7884
HCC2108 CTRP2 5.4374 10.1703 3.456 12.0932
Calu-1 CTRP2 5.4513 8.09 4.4933 7.7629
NCI-H2369 GDSC1; GDSC2 5.4568 12.3806 0.4246 11.9582
NCI-H2170 GDSC1; GDSC2; CTRP2 5.4616 10.0298 3.5474 11.6643
A-549 GDSC1; GDSC2; CTRP2 5.4713 9.3768 3.8794 10.2669
HCC1833 CTRP2 5.4814 10.868 3.1488 13.2585
LUDLU-1 CTRP2 5.5231 9.0665 4.0796 9.3216
NCI-H1623 GDSC1; GDSC2; CTRP2 5.7087 9.7329 3.9134 9.6231
LC-1/sq-SF CTRP2 5.7166 6.9498 5.2961 3.841
NCI-H526 GDSC1; GDSC2; CTRP2 5.7667 11.2721 3.1957 12.4744
NCI-H1651 GDSC1; GDSC2; CTRP2 5.7789 8.5911 4.5436 6.8402
HOP-62 GDSC1; GDSC2; CTRP2 5.7839 9.6984 3.996 9.1234
RERF-LC-Ad2 CTRP2 5.802 10.5181 3.6025 10.7271
NCI-H322 CTRP2 5.8123 9.7482 3.9957 9.067
T3M-10 CTRP2 5.871 7.9941 4.9215 5.0654
NCI-H1734 GDSC1; GDSC2; CTRP2 5.8852 9.8547 4.005 8.8814
NCI-H1869 GDSC1; GDSC2; CTRP2 5.9678 10.877 3.564 10.5563
NCI-H460 GDSC1; GDSC2; CTRP2 5.9962 15.4295 1.3116 19.1233
NCI-H727 GDSC1; GDSC2; CTRP2 5.9973 9.7153 4.1696 7.9702
NCI-H2342 GDSC1; GDSC2; CTRP2 6.1651 11.4652 3.4339 10.7116
HCC827 GDSC1; GDSC2; CTRP2 6.222 11.9239 3.2513 11.3527
NCI-H2444 GDSC1; GDSC2; CTRP2 6.2328 9.405 4.5184 6.0595
HCC78 GDSC1; GDSC2; CTRP2 6.2517 12.4661 3.0046 12.2962
HCC2935 CTRP2 6.3088 9.2112 4.6756 5.2631
EKVX GDSC1; GDSC2; CTRP2 6.5985 9.7657 4.6229 4.9866
NCI-H1395 CTRP2 6.7741 10.0738 4.6007 4.7963
NCI-H1299 GDSC1; GDSC2; CTRP2 6.7951 12.1469 3.594 8.914
NCI-H292 GDSC1; GDSC2; CTRP2 6.9677 15.7164 1.9547 15.0085
NCI-H650 GDSC1; GDSC2; CTRP2 7.0135 14.4955 2.5968 12.5185
NCI-H2126 CTRP2 7.0385 11.792 3.9511 7.0472
BEN GDSC1; GDSC2; CTRP2 7.1633 8.2488 5.6769 0.3252
Calu-6 GDSC1; GDSC2; CTRP2 7.184 12.3383 3.7893 7.4771
NCI-H1435 GDSC1; GDSC2; CTRP2 7.2058 10.887 4.5093 4.5247
COLO 699 CTRP2 7.2765 15.4495 2.325 13.0986
RERF-LC-Ad1 CTRP2 7.3318 8.2493 5.7455 0.1247
HCC1171 CTRP2 7.4324 11.7201 4.2633 5.1904
MOR/CPR CTRP2 7.4835 9.9921 5.1017 1.8984
NCI-H196 GDSC1; GDSC2; CTRP2 7.5359 12.084 4.159 5.4616
NCI-H441 GDSC1; GDSC2; CTRP2 7.5484 9.9129 5.1731 1.5835
NCI-H2030 GDSC1; GDSC2; CTRP2 7.6368 10.9171 4.7725 2.9416
LCLC-103H GDSC1; GDSC2; CTRP2 7.9642 9.1794 5.6525 0.1128
NCI-H1838 GDSC1; GDSC2; CTRP2 8.3503 14.0035 3.7833 5.8458
NCI-H2023 GDSC1; GDSC2; CTRP2 8.3782 13.9774 3.8132 5.6958
NCI-H2291 GDSC1; GDSC2; CTRP2 8.4394 10.2833 5.4388 0.3133
Hs 888.Lu CTRP2 4.9055 11.5067 2.3144 17.8276
⏷ Show the Full List of 222 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Lymphoma Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
CBTCi002-A GDSC1; GDSC2 3.4558 6.3642 1.9109 8.2518
Cancer Drug Sensitivity Data Curated from 3 Cell Line(s) in Thigh Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
H-STS CTRP2 2.9999 7.9494 2.0602 23.6634
SYO-1 CTRP2 3.2406 9.252 1.7605 24.0591
P-STS CTRP2 5.3895 10.6201 3.1903 13.2857
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Clivus Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
U-CH1 CTRP2 6.6211 9.9884 4.53 11.3036
Cancer Drug Sensitivity Data Curated from 31 Cell Line(s) in Soft Tissue Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
Aska-SS CTRP2 7.6914 9.1676 5.5504 0.3699
Yamato-SS CTRP2 8.4269 21.7385 0.0836 18.5916
A-204 GDSC1; GDSC2; CTRP2 -3.2357 4.7022 -3.7508 59.1197
G-402 GDSC1; GDSC2; CTRP2 -2.3873 6.6282 -3.3232 54.4563
STS-0421 GDSC1; GDSC2 1.0995 4.6579 0.4353 24.9712
EW-8 GDSC1; GDSC2 1.4855 2.935 1.4086 18.175
G-401 GDSC1; GDSC2; CTRP2 1.6721 4.5315 1.5847 29.4224
Rh41 GDSC1; GDSC2; CTRP2 2.0246 4.6151 1.9492 27.0349
TTC-709 CTRP2 2.0246 7.1098 1.3264 29.148
Rh18 GDSC1; CTRP2 3.3312 5.8634 3.1308 18.7719
MES-SA GDSC1; GDSC2; CTRP2 3.3596 7.1881 2.7384 20.1294
SW684 GDSC1; GDSC2 3.8101 5.9612 2.3837 4.5013
Hs 633.T GDSC1; GDSC2 3.9975 6.5839 2.2139 5.0948
TE 441.T GDSC2; CTRP2 4.0166 7.6235 3.2641 16.2967
GCT GDSC1; GDSC2; CTRP2 4.0325 6.0651 3.843 14.067
SW872 GDSC1; GDSC2 4.1316 6.2251 2.4769 3.2857
VA-ES-BJ GDSC1; GDSC2 4.3334 8.5984 1.4717 8.7121
KYM-1 GDSC1; GDSC2; CTRP2 4.4289 7.8442 3.5974 13.8966
HT-1080 GDSC1; GDSC2; CTRP2 4.4703 6.7646 4.0874 11.8784
SK-UT-1 GDSC1; GDSC2; CTRP2 4.5879 9.009 3.2239 14.987
Hs 729.T CTRP2 4.6272 9.6538 2.9556 15.9651
TE 617.T CTRP2 4.692 8.3762 3.6222 13.1293
MFH-ino GDSC1; GDSC2 4.9883 7.5709 2.3728 2.4699
RKN GDSC1; GDSC2; CTRP2 5.1886 9.3348 3.641 11.8783
Rh30 GDSC1; GDSC2 5.4157 14.1106 -0.4426 16.1291
SK-LMS-1 GDSC1; GDSC2; CTRP2 5.5609 9.7779 3.7608 10.5679
RD GDSC1; GDSC2; CTRP2 5.7916 10.1727 3.766 10.0683
BT-12 CTRP2 7.3076 13.8726 3.1267 9.9455
Tm87-16 CTRP2 7.4472 17.4331 1.4727 15.8662
BT-16 CTRP2 7.6949 9.1364 5.5637 0.3396
SW982 GDSC1; GDSC2; CTRP2 7.9166 9.0822 5.669 0.1021
⏷ Show the Full List of 31 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 43 Cell Line(s) in Ovary Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
A2780 GDSC1; GDSC2; CTRP2 1.0826 4.6877 0.9304 33.5512
COV434 CTRP2 2.4101 7.8665 1.4655 27.4876
Caov-3 GDSC2; CTRP2 2.6463 4.9747 2.5638 22.9185
JHOS-4 GDSC1; GDSC2 3.1206 7.1334 1.2459 13.1971
TOV-112D GDSC1; GDSC2; CTRP2 3.6243 8.3714 2.5391 20.1448
OVK18 GDSC1; GDSC2; CTRP2 3.6789 10.1881 1.7774 22.8182
DOV13 GDSC1; GDSC2; CTRP2 4.0032 6.965 2.0322 5.1776
ES-2 GDSC1; GDSC2 4.2118 7.7132 1.8165 6.971
OVCAR-3 GDSC1; GDSC2 4.2899 8.0554 1.7053 7.45
OV-90 GDSC1; GDSC2; CTRP2 4.3206 6.903 3.8747 13.1093
OAW42 GDSC1; GDSC2; CTRP2 4.3971 8.3268 3.3496 14.9608
OVISE GDSC1; GDSC2; CTRP2 4.5151 6.9306 2.3884 2.6035
JHOM-1 CTRP2 4.5807 7.4623 3.9199 12.2263
MCAS CTRP2 4.5931 7.705 3.8269 12.5614
OVCAR-8 GDSC1; GDSC2; CTRP2 4.6717 7.3409 4.0663 11.4104
IGROV-1 GDSC1; GDSC2; CTRP2 4.7386 10.3628 2.7194 16.6384
TYK-nu GDSC1; GDSC2; CTRP2 4.7484 7.6576 4.0063 11.4478
COV362 CTRP2 4.9161 18.4634 -1.1287 28.2917
OVCAR-5 GDSC1; GDSC2; CTRP2 5.0035 9.0771 3.5923 12.5023
OVKATE GDSC1; GDSC2 5.0132 8.7074 1.8742 5.0641
ONCO-DG-1 CTRP2 5.0483 8.8517 3.7436 11.7789
Caov-4 GDSC1; GDSC2 5.3528 12.9675 0.0689 13.9183
SNU-119 CTRP2 5.369 9.7166 3.619 11.5686
JHOS-2 GDSC1; GDSC2; CTRP2 5.3718 9.8424 3.5594 11.8085
OVCAR-4 GDSC1; GDSC2; CTRP2 5.3743 11.3774 2.8008 14.8899
OV7 CTRP2 5.4295 13.3007 1.8919 18.2535
SNU-8 CTRP2 5.4746 9.5918 3.776 10.6891
EFO-21 GDSC1; GDSC2; CTRP2 5.5443 7.7314 4.7548 6.4699
FU-OV-1 GDSC1; GDSC2; CTRP2 5.6297 9.1998 4.1091 8.9708
HEY A8 CTRP2 5.7102 10.1617 3.701 10.505
EFO-27 GDSC1; GDSC2; CTRP2 5.8335 8.7825 4.4959 6.9277
COV644 CTRP2 5.8939 8.0616 4.9078 5.0759
TOV-21G GDSC1; GDSC2; CTRP2 6.0167 10.464 3.8115 9.4311
SNU-840 CTRP2 6.0265 8.7249 4.6892 5.7307
OC 314 GDSC1; GDSC2; CTRP2 6.3374 10.689 3.9616 8.1997
RMG-I GDSC1; GDSC2; CTRP2 6.6888 11.0325 4.0649 7.1517
OAW28 GDSC1; GDSC2; CTRP2 6.762 10.8894 4.1908 6.508
OV56 GDSC1; GDSC2; CTRP2 7.2039 13.4359 3.2649 9.564
OVSAHO CTRP2 7.5214 13.894 3.2721 9.0272
Kuramochi GDSC1; GDSC2; CTRP2 7.575 10.8954 4.7447 3.1192
OVTOKO GDSC1; GDSC2; CTRP2 7.7276 11.5214 4.5492 3.6814
SK-OV-3 GDSC1; GDSC2; CTRP2 7.8866 11.2568 4.7662 2.6878
JHOC-5 CTRP2 8.6602 13.3896 4.2548 3.7209
⏷ Show the Full List of 43 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 8 Cell Line(s) in Pleura Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
MSTO-211H GDSC1; GDSC2; CTRP2 2.8031 4.8683 2.7451 21.7903
MPP 89 GDSC1; GDSC2; CTRP2 3.6527 7.119 3.0784 18.0162
NCI-H28 GDSC1; GDSC2; CTRP2 4.1869 7.515 3.4876 14.9693
NCI-H2452 GDSC1; GDSC2; CTRP2 4.193 7.3417 3.5654 14.6509
IST-Mes1 GDSC1; GDSC2; CTRP2 4.333 9.5115 2.7379 17.5418
ACC-MESO-1 CTRP2 5.1655 8.16 4.1876 9.6845
JL-1 CTRP2 5.3644 7.7016 4.5981 7.5329
NCI-H2052 GDSC1; GDSC2; CTRP2 6.6015 11.7672 3.633 9.0896
⏷ Show the Full List of 8 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 7 Cell Line(s) in Prostate Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
PC-3 GDSC1; GDSC2 4.0109 7.1379 1.9532 6.6136
LNCaP clone FGC GDSC1; GDSC2; CTRP2 4.2074 9.2962 2.7149 17.9451
VCaP GDSC1; GDSC2; CTRP2 4.6347 9.0272 3.2609 14.7241
NCI-H660 GDSC2 4.7417 6.1354 2.8493 0.645
22Rv1 GDSC1; GDSC2 4.7612 10.713 0.7464 11.7944
PaCa-3 CTRP2 5.5744 7.0331 5.1191 4.903
DU145 GDSC1; GDSC2; CTRP2 5.6523 9.7309 3.865 9.9422
⏷ Show the Full List of 7 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 2 Cell Line(s) in Salivary Gland Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
YD-15 CTRP2 4.7561 7.5496 4.0621 11.2061
A-253 GDSC1; GDSC2; CTRP2 5.1847 8.8563 3.8705 10.9424
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Small Intestine Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
HuTu 80 GDSC1; GDSC2 -0.8008 3.6696 -1.2769 41.4674
Cancer Drug Sensitivity Data Curated from 44 Cell Line(s) in Stomach Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
HSC-39 GDSC1; GDSC2 -2.4612 -0.8582 -2.4617 56.0158
SNU-16 GDSC1; GDSC2; CTRP2 -1.1836 2.5703 -1.2326 48.1994
NCC-StC-K140 CTRP2 1.1924 10.9909 -1.1046 38.0515
HGC-27 GDSC1; GDSC2; CTRP2 1.5457 4.769 1.415 30.4084
SNU-620 CTRP2 1.6109 2.7526 1.6107 29.5375
ECC10 GDSC1; GDSC2; CTRP2 1.7111 3.9585 1.682 28.9665
KATO III GDSC1; GDSC2; CTRP2 1.9044 9.5553 0.2481 32.7479
SK-GT-2 GDSC1; GDSC2 2.0116 5.572 0.9793 18.4181
GSS CTRP2 2.4509 5.2541 2.3068 24.4326
MKN1 GDSC1; GDSC2 3.2693 5.788 2.0448 7.9543
TGBC11TKB GDSC1; GDSC2 3.3686 7.2637 1.3897 11.6309
SNU-1 GDSC1; GDSC2; CTRP2 3.4885 6.2773 3.1882 18.0866
SCH GDSC1; GDSC2 3.6414 5.9591 2.2592 5.6523
RF-48 GDSC1; GDSC2 3.678 6.1531 2.191 5.9748
Fu97 GDSC1; GDSC2; CTRP2 3.7506 10.6578 1.6286 23.1576
TMK-1 GDSC1; GDSC2 3.9888 7.1798 1.9166 6.8825
GCIY GDSC1; GDSC2 4.2596 7.2766 2.0609 5.4358
ECC12 GDSC2; CTRP2 4.3347 7.5111 3.6436 13.9639
23132/87 GDSC1; GDSC2; CTRP2 4.3844 6.5211 4.0834 12.1391
LMSU CTRP2 4.5218 17.7363 -1.1144 29.1214
HuG1-N CTRP2 4.5454 7.8786 3.7012 13.1833
IM95 GDSC1; GDSC2; CTRP2 4.648 7.3517 4.037 11.588
OCUM-1 GDSC1; GDSC2; CTRP2 4.7928 10.3256 2.7884 16.2394
SNU-216 CTRP2 4.863 6.2974 4.6781 8.5302
SNU-601 CTRP2 5.0822 7.1774 4.56 8.3851
RERF-GC-1B GDSC1; GDSC2 5.3957 18.4473 -2.5897 23.9846
MKN7 GDSC1; GDSC2; CTRP2 5.5106 8.7796 4.21 8.8062
MKN28 GDSC1; GDSC2 5.6315 13.4725 0.0186 13.567
KE-39 CTRP2 5.8621 10.3189 3.7533 9.9789
SNU-719 CTRP2 5.9142 10.5728 3.6708 10.2188
SH-10-TC CTRP2 5.9338 9.0087 4.4691 6.838
SNU-5 GDSC1; GDSC2; CTRP2 6.0102 9.9547 4.0607 8.4015
Hs 746.T GDSC1; GDSC2; CTRP2 6.0289 10.9265 3.5904 10.3273
MKN74 CTRP2 6.1125 9.3938 4.4261 6.6717
GSU CTRP2 6.224 8.4358 4.9949 4.0768
NUGC-4 GDSC1; GDSC2; CTRP2 7.1702 12.1515 3.8707 7.1675
SNU-668 CTRP2 7.1895 11.112 4.3897 5.0296
MKN45 GDSC1; GDSC2; CTRP2 7.2725 12.0154 4.0102 6.4434
NCI-N87 GDSC1; GDSC2; CTRP2 7.9204 10.6714 5.0439 1.6824
AGS GDSC1; GDSC2; CTRP2 8.0763 13.8895 3.6586 6.6895
NUGC-3 GDSC1; GDSC2; CTRP2 8.7628 15.8225 3.1928 7.5568
SNG-M GDSC1; GDSC2; CTRP2 4.8496 8.0377 3.9353 11.477
SNU-1077 CTRP2 5.171 9.7987 3.3975 12.9178
SNU-685 CTRP2 5.9244 9.9759 3.9777 8.9176
⏷ Show the Full List of 44 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 18 Cell Line(s) in Thyroid Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SW579 CTRP2 -2.2225 4.4674 -2.601 54.2735
CGTH-W-1 GDSC1; GDSC2; CTRP2 -2.0023 1.7601 -2.0332 53.5179
K5 GDSC1; GDSC2 3.1206 4.9481 2.3355 6.6192
KMH-2 GDSC1; GDSC2 3.425 7.2322 1.452 11.1035
HTC-C3 GDSC1; GDSC2 3.551 6.0319 2.1528 6.5281
FTC-238 CTRP2 3.5748 8.7425 2.327 21.0785
IHH-4 GDSC1; GDSC2 3.6763 7.1708 1.6843 9.0401
TT2609-C02 GDSC1; GDSC2; CTRP2 3.9363 7.433 3.2577 16.5409
ML-1 [Human leukemia] GDSC1; GDSC2; CTRP2 3.9378 8.5139 2.7995 18.3097
8305C GDSC1; GDSC2; CTRP2 4.1303 6.6651 3.7582 14.091
B-CPAP GDSC1; GDSC2; CTRP2 4.1858 6.6744 3.8148 13.719
8505C GDSC1; GDSC2; CTRP2 4.4502 8.3073 3.4119 14.5779
CAL-62 GDSC1; GDSC2; CTRP2 4.6041 6.9316 4.1652 11.2079
ASH-3 GDSC1; GDSC2 4.6412 7.2865 2.3014 3.3629
TT GDSC1; GDSC2; CTRP2 4.8887 8.6303 3.696 12.351
FTC-133 GDSC1; GDSC2; CTRP2 5.4516 9.6267 3.738 10.8964
BHT-101 GDSC1; GDSC2; CTRP2 7.2527 9.981 4.9688 2.652
WRO GDSC1; GDSC2 7.5526 18.7432 -1.2122 15.0918
⏷ Show the Full List of 18 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 56 Cell Line(s) in Upper Aerodigestive Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
PCI-06A GDSC1; GDSC2 0.949 4.42 0.3672 25.966
HO-1-N-1 GDSC1; GDSC2 1.3289 2.53 1.3011 19.4447
BB30-HNC GDSC1; GDSC2 1.9575 4.5678 1.374 16.3824
DOK GDSC1; GDSC2 2.2738 5.9036 1.0795 16.9046
PCI-38 GDSC1 2.3807 5.2221 -0.1015 4.7652
BB49-HNC GDSC1 2.4336 4.9052 0.0731 3.4636
CAL-27 GDSC1; GDSC2; CTRP2 2.5671 7.8438 1.6417 26.4129
JHU-011 GDSC1; GDSC2 2.742 7.4434 0.7599 17.1506
OSC-20 GDSC1; GDSC2 2.8005 6.8742 1.0945 15.0621
BICR 18 CTRP2 3.0544 10.2889 1.1071 26.7895
PCI-15A GDSC1; GDSC2 3.2883 7.6411 1.1343 13.3607
YD-8 CTRP2 3.3319 5.7809 3.1517 18.6954
PCI-04B GDSC1; GDSC2 3.6122 8.1045 1.1681 12.2631
NCI-H3118 GDSC1; GDSC2 3.7934 8.6921 1.0189 12.6384
Ca9-22 GDSC1; GDSC2 3.8363 6.6177 2.0806 6.258
KON GDSC1; GDSC2 3.877 11.1491 -0.1392 18.4723
PE/CA-PJ34 (clone C12) CTRP2 3.9929 6.4223 3.692 14.7378
KOSC-2 GDSC1; GDSC2 4.0821 10.9566 0.1181 16.6859
BICR 78 GDSC1; GDSC2 4.0868 9.0634 1.0611 11.6522
HSC-2 GDSC1; GDSC2; CTRP2 4.1237 7.4013 3.4682 15.2159
SCC-15 GDSC1; GDSC2 4.1261 8.5014 1.368 9.7955
OSC-19 GDSC1; GDSC2 4.1386 6.5049 2.3488 4.0082
SCC-25 GDSC1; GDSC2; CTRP2 4.1414 7.1492 3.5881 14.7056
BICR 10 GDSC1; GDSC2 4.2091 8.8131 1.276 10.1291
UPCI-SCC-090 GDSC1; GDSC2 4.4452 8.3992 1.6476 7.4485
PE/CA-PJ49 CTRP2 4.4616 6.857 4.0429 12.0727
HO-1-u-1 GDSC1; GDSC2 4.5379 8.2554 1.7802 6.4898
SAS GDSC1; GDSC2 4.5951 9.2349 1.3475 8.8448
SKN-3 GDSC1; GDSC2 4.6653 7.3354 2.2935 3.366
LB771-HNC GDSC1; GDSC2 4.6872 13.4027 -0.6308 18.6221
PE/CA-PJ15 GDSC1; GDSC2; CTRP2 4.7335 7.0196 4.266 10.464
PCI-30 GDSC1; GDSC2 4.7409 9.7825 1.1842 9.448
Detroit 562 GDSC1; GDSC2; CTRP2 4.8436 10.0403 2.9748 15.3783
SAT [Human HNSCC] GDSC1; GDSC2 4.9239 15.1307 -1.3064 20.7715
BHY GDSC1; GDSC2; CTRP2 4.9363 7.8425 4.1116 10.5506
JHU-029 GDSC1; GDSC2 4.9561 13.3772 -0.4173 17.0533
YD-10B CTRP2 4.9764 8.8318 3.6844 12.1896
JHU-022 GDSC1; GDSC2 5.0038 12.4326 0.0809 14.6329
SCC-4 GDSC1; GDSC2; CTRP2 5.164 9.7714 3.4044 12.9052
FaDu GDSC1; GDSC2; CTRP2 5.4089 9.6917 3.6674 11.2815
CAL-33 GDSC1; GDSC2; CTRP2 5.5253 9.7891 3.7236 10.7982
BICR 16 CTRP2 5.5936 9.7896 3.784 10.4025
SCC-9 GDSC1; GDSC2; CTRP2 5.6855 10.1293 3.6957 10.5779
SNU-1076 CTRP2 5.6948 9.4473 4.0434 9.1087
BICR 6 CTRP2 5.712 10.4557 3.5559 11.1036
BICR 56 CTRP2 5.7462 11.7388 2.945 13.5325
HSC-4 GDSC1; GDSC2; CTRP2 5.8745 10.4567 3.6951 10.1967
SNU-1214 CTRP2 6.6636 9.9975 4.5572 5.1528
PE/CA-PJ41 (clone D2) CTRP2 6.9226 12.6934 3.4204 9.4053
SNU-46 CTRP2 7.0254 11.0174 4.3204 5.5562
BICR 22 GDSC1; GDSC2; CTRP2 7.2234 14.8024 2.605 12.1256
SNU-899 CTRP2 7.4739 10.4299 4.8974 2.6604
HSC-3 GDSC1; GDSC2; CTRP2 7.9943 12.4401 4.2887 4.3532
SNU-1066 CTRP2 8.2294 9.5091 5.6339 0.0901
SNU-1041 CTRP2 8.4887 12.26 4.6596 2.4661
BICR 31 GDSC2; CTRP2 9.9819 23.1378 0.5149 15.0019
⏷ Show the Full List of 56 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 25 Cell Line(s) in Urinary Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
JMSU-1 CTRP2 0.0898 3.1738 0.05 39.7893
UM-UC-1 CTRP2 0.2313 5.5474 -0.1711 39.7676
RT-112 GDSC1; GDSC2; CTRP2 1.4338 5.8601 1.0619 31.9357
5637 GDSC1; GDSC2; CTRP2 1.9448 3.7055 1.9353 27.3437
U-BLC1 CTRP2 2.4884 8.7656 1.1888 28.1656
RT-4 GDSC1; GDSC2; CTRP2 3.2675 10.2865 1.3222 25.4942
SW780 GDSC1; GDSC2 3.7439 7.739 1.4544 10.2367
CAL-29 GDSC1; GDSC2 3.8209 7.5277 1.619 9.0635
647V GDSC1; GDSC2; CTRP2 3.9426 8.6925 2.7248 18.5863
253J CTRP2 4.1395 6.5703 3.8014 13.9024
VM-CUB-1 CTRP2 4.3817 7.687 3.6172 13.9424
TCCSUP GDSC1; GDSC2; CTRP2 4.3861 8.4412 3.2866 15.239
BFTC-905 GDSC1; GDSC2; CTRP2 4.6259 6.9464 4.1823 11.0819
UM-UC-3 GDSC1; GDSC2; CTRP2 4.6265 7.2485 4.0586 11.5608
639V GDSC1; GDSC2; CTRP2 4.844 8.1928 3.8579 11.8029
J82 GDSC1; GDSC2; CTRP2 4.8446 9.7354 3.1236 14.7778
SW1710 GDSC1; GDSC2; CTRP2 4.8886 8.6447 3.6891 12.3793
KMBC-2 CTRP2 4.8993 9.7564 3.165 14.4831
253J-BV CTRP2 4.9543 8.8436 3.6576 12.351
HT-1197 GDSC1; CTRP2 5.1347 7.4912 4.4713 8.6068
BC-3C CTRP2 5.151 8.9233 3.8063 11.2838
T24 GDSC1; GDSC2; CTRP2 5.4318 11.7197 2.6813 15.2407
HT-1376 GDSC1; GDSC2; CTRP2 5.8067 9.6779 4.0259 8.952
SCaBER CTRP2 6.422 16.8351 0.9604 19.4475
KU-19-19 GDSC1; GDSC2; CTRP2 7.1047 12.0105 3.8922 7.1827
⏷ Show the Full List of 25 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 39 Cell Line(s) in Urogenital System Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
NEC8 GDSC1; GDSC2 -0.1264 3.0966 -0.3822 34.5704
NT2-D1 GDSC1; GDSC2 0.4499 2.5827 0.3541 28.2956
TC-YIK GDSC1; GDSC2 1.05 2.7371 0.9742 22.3864
PWR-1E GDSC1; GDSC2 1.4455 5.5496 0.4191 23.6299
MS751 GDSC1; GDSC2 1.9004 5.0559 1.1022 18.1408
SW954 GDSC1; GDSC2 1.9473 4.3499 1.4548 15.9666
CAL-39 GDSC1; GDSC2 2.6889 5.5158 1.6612 12.0728
C-33 A GDSC1; GDSC2 2.7412 5.5107 1.7125 11.5934
DSH1 GDSC1; GDSC2 2.9355 5.0103 2.1374 8.4031
HeLa GDSC1; GDSC2; CTRP2 3.3428 8.2389 2.3025 21.8054
Ca Ski GDSC1; GDSC2 3.3609 7.5658 1.2324 12.5812
SW756 GDSC1; GDSC2 3.4006 48.8577 -19.3804 43.734
BPH-1 GDSC1; GDSC2 3.4446 7.6516 1.2584 12.194
OV17R GDSC1; GDSC2 3.5096 8.3332 0.9709 13.6758
NCC-IT GDSC2 3.5256 7.7581 1.2712 12.3056
JEG-3 GDSC1; GDSC2 3.5695 8.7235 0.8246 14.3346
JAR GDSC1; GDSC2 3.5868 6.415 1.9902 7.4231
PA-1 GDSC1; GDSC2 3.637 7.3237 1.5772 9.7841
HEC-1 GDSC1; GDSC2 3.6821 7.1488 1.6997 8.9325
UWB1.289 GDSC1; GDSC2 3.6996 6.1168 2.2254 5.7141
LB831-BLC GDSC1; GDSC2 3.7187 6.1485 2.2241 5.675
SKN GDSC1; GDSC2 3.7225 18.6734 -4.0226 31.3881
SKG-IIIa GDSC1; GDSC2 3.8488 5.8847 2.4487 4.0277
HT-3 GDSC1; GDSC2 3.9639 6.5224 2.22 5.1322
SiHa GDSC1; GDSC2 3.9804 7.1448 1.9276 6.8364
ME-180 GDSC1; GDSC2 4.2441 8.8862 1.266 10.1039
KGN GDSC1; GDSC2 4.2642 7.0647 2.1656 4.818
SiSo GDSC1; GDSC2 4.3231 8.8203 1.3559 9.4038
DoTc2 4510 GDSC1; GDSC2 4.3425 6.9045 2.293 3.9349
ACC-OV7 GDSC1; GDSC2 4.5225 9.6035 1.1168 10.3067
HEY GDSC1; GDSC2 4.5327 29.7867 -8.9155 36.6918
OVCA420 GDSC1; GDSC2 4.662 7.0131 2.4373 2.6062
SW962 GDSC1; GDSC2 4.7036 8.1086 1.9588 5.1508
OVMIU GDSC1; GDSC2 5.0056 7.9043 2.2351 3.1447
OMC-1 [Human cervical carcinoma] GDSC1; GDSC2 5.2602 7.734 2.4451 1.794
C-4-I GDSC1; GDSC2 5.2623 17.0512 -2.0003 22.4401
OVCA433 GDSC1; GDSC2 5.2921 11.6975 0.6406 11.202
PEO1 GDSC1; GDSC2 5.4437 12.6938 0.2647 12.7771
JHOS-3 GDSC1; GDSC2 6.2521 8.0022 2.7598 0.1925
⏷ Show the Full List of 39 Cancer Drug Sensitivity Data of This Drug

Drug-Drug Interaction (DDI) Information of This Drug

Coadministration of a Drug Treating the Disease Different from Axitinib (Comorbidity)
DDI Drug Name DDI Drug ID Severity Mechanism Comorbidity REF
Remdesivir DMBFZ6L Moderate Increased risk of hepatotoxicity by the combination of Axitinib and Remdesivir. 1D6YCoronavirus Disease 2019 [1D6YCoronavirus Disease 2019] [10]
Ivosidenib DM8S6T7 Moderate Increased metabolism of Axitinib caused by Ivosidenib mediated induction of CYP450 enzyme. Acute myeloid leukaemia [2A60] [11]
Arn-509 DMT81LZ Major Increased metabolism of Axitinib caused by Arn-509 mediated induction of CYP450 enzyme. Acute myeloid leukaemia [2A60] [11]
Bedaquiline DM3906J Moderate Increased risk of hepatotoxicity by the combination of Axitinib and Bedaquiline. Antimicrobial drug resistance [MG50-MG52] [12]
Pexidartinib DMS2J0Z Major Increased metabolism of Axitinib caused by Pexidartinib mediated induction of CYP450 enzyme. Bone/articular cartilage neoplasm [2F7B] [11]
Tucatinib DMBESUA Major Decreased metabolism of Axitinib caused by Tucatinib mediated inhibition of CYP450 enzyme. Breast cancer [2C60-2C6Y] [10]
Osilodrostat DMIJC9X Moderate Decreased metabolism of Axitinib caused by Osilodrostat mediated inhibition of CYP450 enzyme. Cushing syndrome [5A70] [13]
Lumacaftor DMCLWDJ Major Increased metabolism of Axitinib caused by Lumacaftor mediated induction of CYP450 enzyme. Cystic fibrosis [CA25] [11]
Ivacaftor DMZC1HS Moderate Decreased metabolism of Axitinib caused by Ivacaftor mediated inhibition of CYP450 enzyme. Cystic fibrosis [CA25] [13]
MK-8228 DMOB58Q Moderate Decreased metabolism of Axitinib caused by MK-8228 mediated inhibition of CYP450 enzyme. Cytomegaloviral disease [1D82] [13]
SODIUM CITRATE DMHPD2Y Minor Decreased absorption of Axitinib due to altered gastric pH caused by SODIUM CITRATE. Discovery agent [N.A.] [14]
Eslicarbazepine DMZREFQ Moderate Increased metabolism of Axitinib caused by Eslicarbazepine mediated induction of CYP450 enzyme. Epilepsy/seizure [8A61-8A6Z] [11]
Cannabidiol DM0659E Moderate Increased risk of hepatotoxicity by the combination of Axitinib and Cannabidiol. Epileptic encephalopathy [8A62] [13]
Tazemetostat DMWP1BH Moderate Increased metabolism of Axitinib caused by Tazemetostat mediated induction of CYP450 enzyme. Follicular lymphoma [2A80] [11]
Boceprevir DMBSHMF Major Decreased metabolism of Axitinib caused by Boceprevir mediated inhibition of CYP450 enzyme. Hepatitis virus infection [1E50-1E51] [10]
Brentuximab vedotin DMWLC57 Moderate Increased risk of hepatotoxicity by the combination of Axitinib and Brentuximab vedotin. Hodgkin lymphoma [2B30] [15]
Cobicistat DM6L4H2 Major Decreased metabolism of Axitinib caused by Cobicistat mediated inhibition of CYP450 enzyme. Human immunodeficiency virus disease [1C60-1C62] [10]
Teriflunomide DMQ2FKJ Major Increased risk of hepatotoxicity by the combination of Axitinib and Teriflunomide. Hyper-lipoproteinaemia [5C80] [16]
BMS-201038 DMQTAGO Major Increased risk of hepatotoxicity by the combination of Axitinib and BMS-201038. Hyper-lipoproteinaemia [5C80] [17]
Levamlodipine DM92S6N Moderate Decreased metabolism of Axitinib caused by Levamlodipine mediated inhibition of CYP450 enzyme. Hypertension [BA00-BA04] [13]
Lesinurad DMUR64T Moderate Increased metabolism of Axitinib caused by Lesinurad mediated induction of CYP450 enzyme. Inborn purine/pyrimidine/nucleotide metabolism error [5C55] [11]
Berotralstat DMWA2DZ Moderate Decreased metabolism of Axitinib caused by Berotralstat mediated inhibition of CYP450 enzyme. Innate/adaptive immunodeficiency [4A00] [13]
Suvorexant DM0E6S3 Moderate Decreased metabolism of Axitinib caused by Suvorexant mediated inhibition of CYP450 enzyme. Insomnia [7A00-7A0Z] [13]
Crizotinib DM4F29C Moderate Decreased metabolism of Axitinib caused by Crizotinib mediated inhibition of CYP450 enzyme. Lung cancer [2C25] [13]
Ceritinib DMB920Z Major Decreased metabolism of Axitinib caused by Ceritinib mediated inhibition of CYP450 enzyme. Lung cancer [2C25] [10]
Selpercatinib DMZR15V Moderate Decreased metabolism of Axitinib caused by Selpercatinib mediated inhibition of CYP450 enzyme. Lung cancer [2C25] [13]
Calaspargase pegol DMQZBXI Moderate Increased risk of hepatotoxicity by the combination of Axitinib and Calaspargase pegol. Malignant haematopoietic neoplasm [2B33] [18]
Idelalisib DM602WT Major Decreased metabolism of Axitinib caused by Idelalisib mediated inhibition of CYP450 enzyme. Mature B-cell leukaemia [2A82] [10]
IPI-145 DMWA24P Moderate Decreased metabolism of Axitinib caused by IPI-145 mediated inhibition of CYP450 enzyme. Mature B-cell leukaemia [2A82] [13]
Vemurafenib DM62UG5 Moderate Increased metabolism of Axitinib caused by Vemurafenib mediated induction of CYP450 enzyme. Melanoma [2C30] [11]
Dabrafenib DMX6OE3 Major Increased metabolism of Axitinib caused by Dabrafenib mediated induction of CYP450 enzyme. Melanoma [2C30] [11]
Fedratinib DM4ZBK6 Moderate Decreased metabolism of Axitinib caused by Fedratinib mediated inhibition of CYP450 enzyme. Myeloproliferative neoplasm [2A20] [13]
Netupitant DMEKAYI Moderate Decreased metabolism of Axitinib caused by Netupitant mediated inhibition of CYP450 enzyme. Nausea/vomiting [MD90] [13]
Entrectinib DMMPTLH Moderate Decreased metabolism of Axitinib caused by Entrectinib mediated inhibition of CYP450 enzyme. Non-small cell lung cancer [2C25] [13]
Rucaparib DM9PVX8 Moderate Decreased metabolism of Axitinib caused by Rucaparib mediated inhibition of CYP450 enzyme. Ovarian cancer [2C73] [13]
Abametapir DM2RX0I Moderate Decreased metabolism of Axitinib caused by Abametapir mediated inhibition of CYP450 enzyme. Pediculosis [1G00] [19]
Lefamulin DME6G97 Moderate Decreased metabolism of Axitinib caused by Lefamulin mediated inhibition of CYP450 enzyme. Pneumonia [CA40] [20]
Enzalutamide DMGL19D Major Increased metabolism of Axitinib caused by Enzalutamide mediated induction of CYP450 enzyme. Prostate cancer [2C82] [11]
Voxelotor DMCS6M5 Moderate Decreased metabolism of Axitinib caused by Voxelotor mediated inhibition of CYP450 enzyme. Sickle-cell disorder [3A51] [13]
Telotristat ethyl DMDIYFZ Moderate Increased metabolism of Axitinib caused by Telotristat ethyl mediated induction of CYP450 enzyme. Small intestine developmental anomaly [DA90] [13]
Larotrectinib DM26CQR Moderate Decreased metabolism of Axitinib caused by Larotrectinib mediated inhibition of CYP450 enzyme. Solid tumour/cancer [2A00-2F9Z] [13]
LEE011 DMMX75K Moderate Decreased metabolism of Axitinib caused by LEE011 mediated inhibition of CYP450 enzyme. Solid tumour/cancer [2A00-2F9Z] [13]
Fostamatinib DM6AUHV Moderate Decreased metabolism of Axitinib caused by Fostamatinib mediated inhibition of CYP450 enzyme. Thrombocytopenia [3B64] [21]
Brilinta DMBR01X Moderate Decreased metabolism of Axitinib caused by Brilinta mediated inhibition of CYP450 enzyme. Thrombosis [DB61-GB90] [13]
Elagolix DMB2C0E Moderate Increased metabolism of Axitinib caused by Elagolix mediated induction of CYP450 enzyme. Uterine fibroid [2E86] [11]
⏷ Show the Full List of 45 DDI Information of This Drug

Drug Inactive Ingredient(s) (DIG) and Formulation(s) of This Drug

DIG
DIG Name DIG ID PubChem CID Functional Classification
Carmellose sodium E00625 Not Available Disintegrant
Eisenoxyd E00585 56841934 Colorant
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Triacetin E00080 5541 Humectant; Plasticizing agent; Solvent
⏷ Show the Full List of 6 Pharmaceutical Excipients of This Drug
Pharmaceutical Formulation
Formulation Name Drug Dosage Dosage Form Route
Axitinib 1 mg tablet 1 mg Oral Tablet Oral
Axitinib 5 mg tablet 5 mg Oral Tablet Oral
Jump to Detail Pharmaceutical Formulation Page of This Drug

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5659).
2 BDDCS predictions, self-correcting aspects of BDDCS assignments, BDDCS assignment corrections, and classification for more than 175 additional drugs
3 Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
4 Nat Rev Drug Discov. 2013 Feb;12(2):87-90.
5 Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics. Eur J Clin Pharmacol. 2012 May;68(5):645-55.
6 Clinical pharmacology of axitinib. Clin Pharmacokinet. 2013 Sep;52(9):713-25.
7 Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation. Arch Toxicol. 2022 Jul;96(7):1975-1987. doi: 10.1007/s00204-022-03291-5. Epub 2022 Apr 18.
8 Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS. Chem Biol Interact. 2019 Sep 1;310:108744. doi: 10.1016/j.cbi.2019.108744. Epub 2019 Jul 9.
9 MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model. Br J Cancer. 2016 Oct 11;115(8):920-928. doi: 10.1038/bjc.2016.263. Epub 2016 Aug 25.
10 Cerner Multum, Inc. "Australian Product Information.".
11 Pithavala YK, Tortorici M, Toh M, et al "Effect of rifampin on the pharmacokinetics of axitinib (AG-013736) in Japanese and Caucasian healthy volunteers." Cancer Chemother Pharmacol 65 (2010): 563-70. [PMID: 19603168]
12 Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
13 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
14 Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
15 Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
16 Canadian Pharmacists Association.
17 Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
18 Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
19 Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
20 Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
21 Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.